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ABSTRACT 
Gender identity refers to an innate and deeply felt psychological identification as a female, 
male, or some other non-binary gender. Gender identity may be congruent or incongruent with 
the sex assigned at birth. Gender dysphoria refers to the discomfort or distress that gender 
incongruence may cause. If the distress is clinically significant, the individual may need 
gender-affirming treatment. The literature is sparse with respect to the etiology, prevalence, 
and long-term outcomes. The overall aim of this thesis is to further our understanding of gender 
dysphoria regarding neurobiological characteristics, epidemiology, and health following 
gender-affirming treatment. Study I explored the hypothesis that cerebral activation in 
hormone-naïve transgender women (assigned males at birth) on exposure to odorous steroids 
would be in line with their gender identity, and thus similar to cisgender women but different 
to cisgender men. Gender dysphoric transgender women demonstrated a cerebral activation 
pattern that corresponded predominately to that of cisgender females, but also some cisgender 
male characteristics. Study II described the prevalence and changes in incidence of 
applications for change of legal gender and applications to reverse the procedure during 1960-
2010. The incidence of gender dysphoria increased three times for individuals assigned male 
at birth, and two and half time times for individuals assigned female at birth. The increase 
accelerated after 2001. The rate of reversal applications was 2.2% with a significant decline 
over the study period. Study III explored long-term mortality and psychiatric morbidity after 
sex reassignment in a nation-wide cohort study (1973-2003). The overall mortality rate was 
higher in individuals who had undergone legal and medical transition compared with the 
general population for the whole period, but not for the period 1989-2003. Probands had more 
psychiatric inpatient care and suicide attempts compared with controls for the whole period as 
well as the period 1989-2003 (with the exception of suicide attempts). This study cannot 
determine the effectiveness of gender-affirming medical intervention, but the results highlight 
the need for better health care following gender transition. Study IV examined outcomes 
following legal and surgical gender transition, mean (SD) follow-up time 7.2 (7.3) years, by 
means of individual interviews with 16 men (assigned female at birth) and 49 women (assigned 
male at birth). The vast majority of the participants felt gender congruent and global clinically 
improved, but the prevalence of psychiatric morbidity and suicide attempts was high. 
Childhood adversities and adult stressful life events were common. Being born abroad, 
childhood adversities, and not being accepted by others in assigned gender predicted current 
psychiatric morbidity. 
  
SAMMANFATTNING 
En persons könsidentitet beskriver den inre upplevelsen av könstillhörighet. Den kan vara 
kvinnligt, manligt eller något ickebinärt kön. Könsinkongruens innebär att en persons 
könsidentitet inte stämmer överens med det kön som blev tilldelat vid födseln. Könsdysfori är 
det lidande som könsinkongruens ibland orsakar. I de fall lidandet är uttalat kan personer 
behöva könsbekräftande behandling. Bakgrunden till könsdysfori, hur vanligt det är och hur en 
person mår efter behandling är ofullständigt känt. Det övergripande syftet med denna 
avhandling var öka kunskapen om könsdysfori avseende neurobiologiska karakteristiska, 
epidemiologi och hälsa efter könsbekräftande behandling. Studie I undersökte om 
transkvinnor (personer som tillskrivits manligt kön vid födseln men identifierar sig som 
kvinnor) aktiverade hjärnan på liknande sätt som ciskvinnor eller cismän (cispersoner = 
personer utan könsinkongruens eller könsdysfori) när de exponeras för feromoner 
Transkvinnor uppvisade ett aktiveringsmönster mer likt ciskvinnor men med en del cismanliga 
drag. I studie II har vi beskrivit incidensen av ansökningar om ändring av juridiskt kön samt 
tillstånd för operation av könsorganen under 1960-2010. Vi undersökte även antalet 
ansökningar om återgång till det ursprungliga könet. Vi fann att incidensen ökade tre gånger 
för dem som tillskrivits manligt kön vid födseln och två och en halv gång för dem som 
tillskrivits kvinnligt kön. Ökningen var mest uttalad efter 2001. Av de som beviljats ändring av 
juridiskt kön ansökte 2,2 % om att få återgå till ursprungligt kön. Antalet ångeransökningar 
minskade signifikant under den senare delen av tidsperioden. I studie III undersöktes 
överlevnad och psykiatrisk sjuklighet i en nationell kohort av personer som bytt juridisk kön 
och genomgått kirurgisk könsbekräftande behandling mellan 1973-2003. För hela tidsperioden 
fann vi en förhöjd dödlighet och att vård för psykisk sjukdom och självmordsförsök var 
vanligare jämfört med befolkningskontroller. Under den studerade perioden sågs en minskning 
avseende dödlighet och vård för självmordsförsök, där de som bytt juridiskt kön inte skilde sig 
från kontrollerna för perioden 1989-2003. En förhöjd risk att ha vårdats för psykisk sjukdom 
kvarstod dock under hela perioden. Studien var inte designad för att avgöra om 
könsbekräftande behandling förbättrar utfallet men pekar på behovet av bättre 
omhändertagande av personer som genomgått könsbekräftande åtgärder. Studie IV undersökte 
utfallet efter genomgången könsbekräftande behandling. Uppföljningstiden var i genomsnitt 
(SD) 7,2 (7,3) år. Sexton män (personer som tillskrivits kvinnligt kön vid födseln) och 49 
kvinnor (personer som tillskrivits manligt kön vid födseln) intervjuades. En klar majoritet 
rapporterade att de kände sig könskongruenta och generellt förbättrade. Trots detta var psykisk 
sjuklighet och tidigare självmordsförsök vanligt. Det var också vanligt att ha varit utsatt för 
negativa barndomsupplevelser (fysisk eller känslomässig misshandel och/eller sexuella 
  
övergrepp) och att i vuxen ålder varit utsatt för diskriminering, trakasserier samt fysiskt och 
sexuellt våld. Att inte vara född i Sverige, att ha utsatts för negativa barndomsupplevelser och 
att inte vara accepterad i sin könstillhörighet av omgivningen var riskfaktorer för psykisk 
sjuklighet. 
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1 INTRODUCTION 
The word identity, from the Latin identitas, means “the same”. It refers to a mental image of 
sameness with others. “Gender identity” denotes the inner sense of what gender one belongs 
to, the mental sameness with others of that gender (Kohlberg, 1966; Steensma, Kreukels, de 
Vries, & Cohen-Kettenis, 2013).  
The term gender identity is a modern concept (Pfäfflin 2011). Money (1955) introduced the 
term “gender role” and defined it as “all those things that a person says or does to disclose 
himself or herself as having a status of boy or man, girl or a woman, respectively. It includes, 
but is not restricted to, sexuality in the sense of eroticism”. With the work of psychoanalyst 
Stoller (1968), the cognitive developmental psychologist Kohlberg (1966), and others, gender 
identity became seen as something separate from gender role. Money (1994) later described it 
as follows: “Gender identity is the private experience of gender role, and gender role is the 
public manifestation of gender identity. Both are like two sides of the same coin and constitute 
the unity of gender identity and gender role. Gender identity is the sameness, unity, and 
persistence of one’s individuality as male, female, or androgynous, in greater or lesser degree 
especially as it is experienced in self-awareness and behavior.” With the introduction of gender 
identity as a separate concept, gender role was gradually reduced to behaviors, attitudes, and 
personality traits, which in a given society and historical period are typically attributed to, 
expected from, or preferred by persons of that gender (Huston, 1983). 
Today, gender identity and gender role are seen as two among the multiple levels of sex or 
gender (Dhejne & Arver, 2012; Winter et al., (2016); Table 1 provides an overview.  
For most persons, the gender identity is in line with the gender assigned at birth, leading to 
feelings of gender congruence. Gender dysphoria as a symptom denotes the distress that gender 
incongruence may cause when the gender identity is not in line with the gender assigned at 
birth. If the distress is intense and gender-affirming health care is needed to adjust the primary 
and secondary sex characteristics, the individual may fulfill the criteria for the medical 
diagnosis Transsexualism (ICD-10) or Gender Dysphoria (DSM-5) (American Psychiatric 
Association, 2013; World Health Organization, 1992). Gender-affirming medical and surgical 
treatment is described in the Standards of Care version 7 (SOC 7) from the World Professional 
Association for Transgender Health (WPATH) (Coleman et al., 2012). In Sweden, the National 
Board of Health and Welfare have issued national guidelines that adhere closely to the SOC 7. 
Gender-affirming medical treatment aims to alter the bodily characteristics to better align with 
the person’s gender identity and ease gender dysphoria. Examples of gender-affirming medical 
treatment are hormone treatment, hair removal, voice therapy, and surgery; surgery options 
include vaginoplasty, breast augmentation, thyroid chondroplasty surgery, pitch-raising vocal 
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fold surgery, chest reconstructive surgery, and phalloplasty. Fertility preservation should be 
offered prior to hormone treatment and genital surgery (National Board of Health and Welfare, 
2015).  
 
Table 1. Different levels of gender 
 
Legal gender The gender defined in legal documents and birth certificate. 
Chromosomal sex  Karyotype describing the presence or absence of Y and/or X 
chromosomes. 
Hormonal sex Female or male sexual hormone pattern. 
Anatomical sex Female or male primary and secondary sex organs. 
Gender identity The perception of being a man, woman, or some other gender. 
Gender expression How the person expresses their gender identity in a social context 
with more or less well defined social gender characteristics, for 
example the way of dressing. 
Gender role Behaviors, attitudes, and personality traits that in a given society and 
historical period are typically attributed to, expected from, or 
preferred by persons of that gender. 
 
For many years, gender identity was seen as binary: an individual had either a female or a male 
gender identity (Fraser & Knudson, 2017; Wålinder, 1968). However, others have argued that 
gender identity should be seen as a non-binary spectrum, where female and male gender 
identity are two of many gender identities that also include “non-binary”, “gender fluid”, 
“transgender”, “transgender masculine”, or “transgender feminine”. (Beek, Kreukels, Cohen‐
Kettenis, & Steensma, 2015; Bockting, 2008; Cohen-Kettenis & Pfäfflin, 2010; Fisk, 1974; 
Fraser & Knudson, 2017; Richards et al., 2016). The non-binary model is currently reflected 
in SOC 7 from WPATH (Coleman et al., 2012). The author of the summary chapter 
acknowledges the non-binary concept and that not all gender incongruent individuals are 
gender dysphoric, fulfill a medical diagnosis, or need gender-affirming treatment. However, 
the participants in the studies included in this thesis were all gender binary with a medical 
diagnosis of gender dysphoria according to ICD-8, 9, or 10 (World Health Organization, 1967, 
1978, 1992). Therefore, this summary chapter will mainly focus on this group. 
1.1 TERMINOLOGY / LANGUAGE 
The language we use reflects our underlying frames and references. During the past years, the 
conceptualization of gender incongruence and gender dysphoria has changed, as has the 
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language describing the phenomena. The main conceptual change is that among the different 
levels of sex and gender, the personal experience of gender identity has priority. To help 
eliminate stigma, prevent discrimination, and promote health in the transgender group, the use 
of inclusive language that promotes respect and dignity has become increasingly important 
(Bouman et al., 2016; von Vogelsang, Milton, Ericsson, & Strömberg, 2016). A list of 
definitions reflecting some of the changes of the new conceptualization is presented later in 
this section. The language and changes of conceptualization is an ongoing process and the 
definitions in Table 2 reflect the usage in early 2017. 
The last years’ changes in terminology are reflected in the four papers of this thesis. Two 
clarifications regarding the terminology in this summary chapter are necessary to avoid 
confusion. 
First, trans/transgender man (a person assigned female gender at birth who identifies as male) 
or trans/transgender woman (a person assigned male gender at birth who identifies as female) 
will be used to describe individuals before, during, and after medical and legal transition 
(Reisner, et al., 2016a; Winter et al., 2016). Trans/transgender man or woman will replace the 
formerly used terms female-to-male transsexuals (FM, FtM, FTM) or male-to-female 
transsexuals (MF, MtF, MTF) (Reisner, et al., 2016a; Winter et al., 2016). However, tables and 
figures from already published articles will not be changed. In Study IV, a majority of the 
participants who were all post legal and medical transition identified themselves according with 
their new assigned gender. Hence, they will be described as men if assigned female gender at 
birth, or women if assigned male gender at birth. 
Second, when referring to individuals with any of the gender dysphoria diagnoses, I included 
any versions of ICD-8, 9, or10 and or DSM-III-5 (American Psychiatric Association, 1980, 
1987, 1994, 2000, 2013; World Health Organization, 1967, 1978, 1992). 
 
List of definitions 
Not all the definitions in Table 2 are used in this summary chapter, but they are nevertheless 
included to illuminate the changes in how gender incongruence and gender dysphoria have 
been conceptualized. 
 
Table 2. List of definitions. 
 
Androphilic Sexual orientation towards men or masculinity (Reisner, 
et al., 2016a). 
Birth-assigned sex The sex/gender that was assigned at birth. This 
supersedes the term biological sex, natal sex, or actual 
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sex. If chromosomal, gonadal, hormonal, or genital sex 
characteristics are discussed, these terms should be used 
(Bouman et al., 2016). 
Cisgender person (Cis person) A person whose gender identity matches the sex 
assigned at birth and who, unlike transgender people, 
does not experience gender incongruence (Winter et 
al., 2016). 
Gender binary A view that there are only two genders (girls/women 
and boys/men) that are separate and unchanging (Fraser 
& Knudson, 2017). 
Gender-affirming health care   
/Gender-confirming health 
care 
Medical treatments aiming to alter the bodily 
characteristics in order to better align with the person’s 
gender identity and ease gender dysphoria. Examples 
of gender-affirming health care include hormone 
treatments, hair removal, voice therapy, and gender-
affirming surgery (Zeluf et al., 2016). 
Gender-affirming surgery 
  /Gender-confirming surgery 
Range of surgeries that create physical characteristics 
that are in line with gender identity, including 
vaginoplasty, breast augmentation, thyroid 
chondroplasty surgery, pitch-raising vocal fold surgery, 
chest surgery, and phalloplasty. Sometimes referred to 
as sex reassignment surgery (SRS) (Berli et al., 2017). 
Gender dysphoria Distress that gender incongruence may cause (Winter et 
al., 2016; Zeluf et al., 2016). 
Gender Dysphoria Refers to the diagnostic term in DSM-5 (American 
Psychiatric Association, 2013). 
Gender Identity Disorder  Refers to the diagnostic term in DSM-IV and DSM-IV-
TR (American Psychiatric Association, 1994, 2000). 
Gender non-conforming This term refers to people who do not conform to 
society’s expectations for their gender roles or gender 
expression. Another term used for this is “gender-
variant” (Berli et al., 2017; Coleman et al., 2012). 
Gender normative Gender roles and/or gender expression that matches 
social and cultural expectations (Coleman et al., 2012). 
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Gender transition A person’s adoption of characteristics that they feel 
match their gender identity. Gender transition can 
involve social, physical, and legal transition. Social 
transition includes changing appearance (including 
styles of dress and hair), name and pronoun. Legal 
gender recognition includes change of legal gender and 
arranging new identity documents. Physical transition 
can facilitate social transition and includes gender-
affirming medical interventions such as hormone 
therapy and gender-affirming surgery (Berli et al., 2017; 
Winter et al., 2016). 
Gynephilic A sexual orientation towards women or femininity 
(Reisner et al., 2016a). 
Legal gender recognition The process by which a person’s legal gender is 
changed to align with the person’s gender identity 
(Zeluf et al., 2016). 
Read as Denotes how others read or perceive your gender 
(Vancouver Costal Health, 2016). 
Sexual orientation Describes whom one is sexually attracted to. The sexual 
orientation of transgender people should be defined by 
the individual. It is often described based on the lived 
gender. A transgender woman attracted to other women 
would be a lesbian, and a transgender man attracted to 
other men would be a gay man (Bouman et al., 2016; 
Winter et al., 2016). 
Sex reassignment Denotes the process to make a social, legal and physical 
gender transition (Vancouver Costal Health, 2016). 
Sex reassignment surgery  See gender-affirming surgery (Vancouver Costal 
Health, 2016). 
Transfeminine This umbrella term describes people who were assigned 
male at birth, who are transgender, and whose gender 
expression leans towards the feminine (Zeluf et al., 
2016). 
Transmasculine This umbrella term describes people who were assigned 
female at birth, who are transgender, and whose gender 
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expression leans towards the masculine (Zeluf et al., 
2016). 
Transsexual A clinical term which has historically been used to 
describe those transgender people who sought medical 
intervention (hormones, surgery) for gender 
affirmation. The term is less commonly used in the 
present day although some individuals and communities 
maintain a strong and affirmative connection to this 
term (Center of Excellence for Transgender Health, 
2016). 
Transgender person 
 (Trans person) 
A transgender person experiences some degree of 
gender incongruence. It is an umbrella term that 
describes a wide range of people whose gender and/or 
gender expression differ from their assigned sex and/or 
the societal and cultural expectations of their assigned 
sex (Berli et al., 2017; Winter et al., 2016). 
Transgender man 
(Trans man) 
Denotes someone with a male gender identity who was 
assigned female at birth, and is transitioning or has 
transitioned to male phenotype. Also known as female-
to male or FtM (Berli et al., 2017; Winter et al., 2016). 
Transgender woman 
(Trans woman) 
Denotes someone with a female gender identity who 
was assigned male at birth, and is transitioning or has 
transitioned to female phenotype. Also known as male 
to female or MtF (Berli et al., 2017; Winter et al., 2016). 
Transsexualism A medical diagnosis in ICD-10 (World Health 
Organization, 1992), and DSM-III and DSM-III-R 
(American Psychiatric Association, 1980, 1987). 
1.2 CULTARAL AND HISTORICAL REMARKS 
Individuals with gender non-conforming behavior and identities have existed and still exist in 
many cultures and countries. Sometimes they have been seen as having special gifts such as 
being a shaman. Individuals assigned male at birth with gender atypical behavior or expressions 
are recognized as Fa’afafine in the Samoan Islands (Poasa, Blanchard, & Zucker, 2004), Hijra 
in India, Maknyah in Malaysia, Phuying khaam phet in Thailand, Xanith in Oman (Winter, 
2009), Acaults in Myanmar (Coleman, Colgan, & Gooren, 1992), Travesti in Brazil (Kulic, 
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1998), Two spirits in some First Nation people in North America (Stoller, 1976), Sarombavy 
in Madagascar (Green, 1969), Muxes in Mexico, and ‘Yan dandu in Nigeria (Murray, 2000). 
Individuals assigned female at birth with gender non-conforming behavior are less common, 
but the polar explorer Knut Rasmussen described a powerful shaman among indigenous people 
of Greenland who was able to transform herself to a male (Rasmussen, 1930). In Albania, 
“sworn virgins” are individuals assigned female at birth who live and are accepted as males 
(Herdt, 1994). In Afghanistan there is a tradition to allow the youngest child – if there are no 
sons – to be raised as a boy until puberty, after which the child must revert to a female gender 
role (Nordberg, 2015). 
Greek mythology and folk tales in East India include stories of cross-gender behavior and/or 
identity. As in the myth of Teiresias, tales often described that Gods could alter the sex of 
humans either as a favor or a punishment (Green, 1969). Historical descriptions include 
roman emperors who behaved as women or wanted to become a woman, Pope John VIII who 
died after giving birth to a child, and Chevalier d’Eon – a mistress to Louis XV – who lived 
half his life as a man and half her life as woman, to mention a few (Green, 1969). 
1.3 MEDICAL BACKGROUND 
The physician and founder of the German Institut für Sexualwissenschaft in Berlin, Magnus 
Hirschfeld (1868-1935), was the first to distinguish homosexuality (sexual attraction to 
individuals of the same sex) from transsexualism. The phenomenon that some individuals had 
a strong wish to carry the clothes traditionally belonging to the other sex he called 
Transvestitismus. He noticed a subgroup that also had a strong desire to change their sex, which 
was later called genuine transvestism or spiritual transsexualism (Seelischem 
Transsexualismus) (Hirschfeld, 1923). Havelock Ellis (1928) in Britain coined the term 
“Eonism” for the same condition, derived from the name Chevalier d’Eon. In 1949, Cauldwell 
(1949) used the term “Transexualism”, and this was later picked up by Harry Benjamin but 
then spelt with a double s, “Transsexualism” (Benjamin 1966). The first described gender-
affirming surgery took place in Germany. Abraham (1931) reported two individuals’ assigned 
male gender at birth, both of whom had undergone castration, penectomy, and vaginoplasty 
(Abraham, 1931). The Danish painter Einar Wegener described the transition to Lili Elbe in 
her autobiography Man into Woman (Elbe, 1933). This story has also featured as a movie, The 
Danish Girl (2015). Lili Elbe was a patient of Magnus Hirschfelt and Kurt Warnekros. She 
underwent castration and penectomy and had also ovaries implanted in 1930. The following 
year she was legally reassigned as female. She died the same year due to complications 
following a uterus transplantation. A similar case from Germany was described by Huelke 
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(1949). Gender-affirming medical treatment did not become well known, however, until the 
endocrinologist Christian Hamburger presented the medical transition of Christine Joergensen. 
Hamburger described the psychiatric and somatic evaluation, the cross-sex hormone treatment, 
and the surgery performed (castration and penectomy). He also described the necessity of legal 
changes such as permission to wear female clothes in public, legal recognition as a woman, 
and the legal right to undergo castration, which was forbidden in some countries at that time 
(Hamburger, Stürup, & Dahl-Iversen, 1953a). Christine Joergensen become well known, and 
later the same year Hamburger reported that he received letters from 465 patients (76% of 
whom had been assigned male at birth) from all over the world applying to undergo treatment 
(Hamburger, 1953b). Later reports from Stockholm and Oslo described both assigned males (n 
= 8) and females (n = 8) who were treated in a similar protocol as described by Hamburger and 
coworkers (1953) (Anchersen, 1956; Hertz, Tillinger, & Westman, 1961; Vogt, 1968). In 
Casablanca, the French gynecologist George Burou developed the penile skin flap inversion 
vaginoplasty for transgender women in 1956, and later on operated many transgender women. 
He did not publish his work, but his work is described by Hage and coworkers 2007 (Hage, 
Karim, & Laub, 2007), and in the documentary I am a woman now by Michiel van Erp from 
2011.  
The Transsexual phenomenon was published in 1966 by the endocrinologist Harry Benjamin, 
describing what was now called transsexualism and detailing a treatment protocol for the 
condition, which was similar to that of Hamburger (Benjamin 1966). 
Treatment programs for individuals with gender dysphoria were set up in Europe and the USA 
thereafter, and the Harry Benjamin International Gender Dysphoria Association (HBIGDA) – 
today the World Association for Transgender Health (WPATH) – was founded. 
That gender dysphoria should be treated with gender-affirming medical intervention as 
described by Hamburger (1953) and Benjamin (1966) and not with psychotherapy was, and is 
sometimes still, controversial. Attitudes towards gender-affirming medical treatment among 
medical professionals was studied by Green and coworkers and revealed a very restrictive 
attitude (Green, Stoller, & Mac Andrew, 1966). Some argued that the gender-affirming 
treatment should be called transgender mutation and saw it as a pre-psychotic or neurotic 
condition that should be treated with psychotherapy, and that the outcome of gender-affirming 
treatment was not as positive as initially reported (Kubie & Mackie, 1968; Lothstein & Levine, 
1981). The first Standards of Care (SOC) for hormonal and surgical reassignment of gender 
dysphoric persons was published in 1979 (Fraser & Knudson, 2017). They described the 
evaluation procedure, eligibility, and readiness criteria for hormone and surgery treatment. The 
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SOC has been updated many times and the current (2017) version is version 7 (SOC 7) 
(Coleman et al., 2012). 
1.4 DEVELOPMENT OF GENDER-AFFIRMING HEALTH CARE IN SWEDEN 
The endocrinologist Rolf Luft at Karolinska University Hospital in Stockholm and the 
psychiatrist Jan Wålinder at St. Jörgen’s Hospital in Gothenburg introduced evaluation and 
gender-affirming treatment with cross-hormone and gender-affirming genital surgery as 
described by Benjamin (1966) (Wålinder, 1967). Gender teams or treatment centers were 
initially established in Gothenburg and later in Stockholm, Uppsala, Lund, Linköping, and 
Umeå. 
Based on the work of Benjamin, Wålinder outlined diagnostic criteria for transsexualism 
(Wålinder, 1968) and eligibility and readiness criteria for sex reassignment (Wålinder & 
Thuwe, 1975).  
 
Diagnostic criteria, Wålinder (1968): 
1. A sense of belonging to the opposite sex, of having been born with the wrong sex, of being 
one of nature’s extant errors. 
 2. A sense of estrangement with one’s own body; all indications of sex differentiation are 
considered as afflictions and repugnant.  
3. A strong desire to physically resemble the opposite sex and a need for gender-confirming 
medical treatment with cross-sex hormones and surgery.  
4. A desire to be accepted by the community as belonging to the opposite sex. 
 
Eligibility and readiness criteria for sex reassignment, Wålinder & Thuwe (1975): 
1. A clear diagnosis established over at least one year, preferably two years. Onset (since early 
childhood), development, and symptomatology must be typical. Psychiatric observation, 
psychological test designed to evaluate femininity and masculinity, and exclusion of a 
psychiatric illness, and preferably also a period of observation in hospital should be included. 
Somatic causes of the symptoms must have been excluded. 
2. A one-year period of social transition prior to gender-affirming treatment. 
3. Personal and emotional stability, good intellectual capacity, and the absence of signs of 
psychotic reaction in order to cope with the transition. 
4. Physical build, voice, hair growth etc. should “be such that the transsexual will not appear 
too conspicuous”. 
5. Other forms of treatment are either not possible or have no prospect of success. 
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6. A stable social situation. 
7. A continuous contact with the gender team during the treatment period. 
 
A history of cross-dressing, late onset, and not being able to be read as a woman or a man were 
removed as contraindications to sex reassignment in the eighties following the results of a study 
by Lundström (1981). He conducted a follow-up study of 31 (5 assigned females and 26 
assigned males at birth) cases who were not accepted for sex reassignment 1962-1974. The 
reasons for non-acceptance were that they either did not fulfill the diagnostic criteria defined 
by Wålinder (1968) (due to conditions bordering to homosexuality or transvestism) or the 
requirements for sex reassignment (due to low intensity of symptoms or psychosocial 
instability). Lundström found that seven individuals had undergone or commenced transition 
at other clinics, and only five out of thirty-one were satisfied with their situation. The remaining 
individuals still felt gender incongruent, had gender dysphoria, and wanted a legal and medical 
transition. One had committed suicide. Lundström concluded that gender dysphoria that had 
originated in the teenage period or later also seemed (with few exceptions) to persist, just as 
for early onset gender dysphoria. Furthermore, individuals with compulsive cross-dressing had 
great difficulty reconciling themselves with the sex assigned at birth (Lundström, 1981).  
 
Development of endocrine treatment 
The first structured guidelines in Sweden for endocrine therapy were presented in 1995. Prior 
to that, most patient care was provided by physicians especially interested in the patient group 
and often in addition to other clinical duties. In the latter part of the 1990s, care gradually 
became more structured, and was provided at six university hospitals. Contemporary endocrine 
treatment reflects availability and development of pharmaceutical forms, dosing, and types of 
molecules. The most commonly used hormone replacement therapy in females was conjugated 
estrogen from pregnant mares.  
 
Development of surgical treatment 
Regarding surgical treatment, until 1986 transgender women underwent either castration or 
received a neovagina ad modum McIndoe (a split thickness skin graft that was used to line the 
wall of the vagina); thus a neoclitoris was not constructed. The penis flap technique with a 
construction of a neoclitoris has been used since 1986. Transgender men underwent a 
mastectomy and hysterosalpingo-oophorectomy. For those who underwent phalloplasty, an 
abdominal flap was used prior to 1986, and thereafter a pedicled groin flap (Eldh, Berg, & 
Gustafsson, 1997).  
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Development of voice therapy  
Swedish speech and language pathologists and phoniatricians developed voice therapy at an 
early stage and Eva Söderpalm published Transsexualism from a speech and language 
perspective (Söderpalm 1996). 
 
Development of informal national guidelines for transgender health care 
Over the years, informal national guidelines were developed. Individuals presenting with 
gender dysphoria were referred to one of six specialized gender teams at psychiatric clinics. 
The national guidelines included approximately one year of diagnostic evaluation by a 
psychiatrist, a psychologist, and a social worker. Gender binary individuals diagnosed with 
Transsexualism according to ICD-10 were encouraged to start social transition and were then 
referred for gender-affirming treatment. After approximately two years of evaluation and 
treatment, the person could apply to the Legal Board of the National Board of Health and 
Welfare in order to receive permission for gender-affirming genital surgery and a change of 
legal sex status. A medical certificate based on the evaluation process accompanied the 
application. Until 1990, it was common with a two-step procedure where the initial application 
was for name change and sterilization. The second application was for final permission to 
undergo juridical gender reassignment and to obtain permission for gender-confirming genital 
surgery (Dhejne, Öberg, Arver, & Landén, 2014).  
 
Evaluation and treatment of today 
Evaluation and treatment adhere since 2015 to the National guidelines “Good care of adults 
with gender dysphoria” published by the National Board of Health and Welfare. The main 
changes were: (1) a more flexible and individualized evaluation process; (2) that gender-
confirming medical treatment should not be reserved for transgender persons who fulfill the 
criteria of Transsexualism, but could also be offered to those with “other gender identity 
disorders” and “unspecified gender identity disorder”; (3) fertility preservation should be 
offered to patients prior to gender-confirming medical treatment; and (4) facial feminization 
surgery and hip liposuction could be offered in some cases. The guidelines also emphasize the 
importance of working in multidisciplinary teams (The National Board of Health and Welfare, 
2015). 
Below is an overview of gender-affirming treatment included in Swedish state-subsidized 
health care of today (The National Board of Health and Welfare, 2015). 
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Masculinizing hormone treatment is administrated either as testosterone undecanoate (a long-
acting ester) or testosterone enanthate injected intramuscularly every 12 weeks. Transdermal 
testosterone gels are an alternative, and are preferred by some patients despite the 
inconvenience of daily application (National Board of Health and Welfare, 2015).  
 
Masculinization surgery consists of a bilateral mastectomy and chest contouring, and a 
hysterectomy and hysterosalpingo-oophorectomy. For phallus reconstruction, either a free 
anterolateral thigh flap (ALT), or metaoidioplasty is used. In metaoidioplasty, the surgeons use 
the clitoris (which is enlarged by testosterone) for the reconstruction. Further hip liposuction 
should be offered (National Board of Health and Welfare, 2015). 
 
Feminization hormone treatment favors the use of transdermal estradiol administration, though 
injections and oral preparations are also used. Synthetic derivatives are avoided because they 
seem to carry an increased risk for thrombosis. Gestagens have been a part of treatment not 
least due to their anti-androgenic effects. Medroxyprogesterone and the more potent 
cyproterone acetate are still being used despite side effects such as depression and 
hyperprolactinemia (National Board of Health and Welfare, 2015). 
 
Feminization surgery, thyroid chondroplasty surgery, is offered, as well as pitch-raising vocal 
fold surgery f voice therapy is insufficient. Regarding vaginoplasty genital surgery, the most 
common technique is the use of solely penile skin to create the intra-vaginal lining in a two-
step procedure. Skin grafts and large bowel segments are rarely used for vaginal lining (Eldh 
et al., 1997). Facial feminization surgery has been performed in some cases since 2015 
(Lundgren et al., 2016). 
 
Voice therapy is offered to all transgender women, and the treatment has been the subject of 
research (Söderpalm, Larsson, & Almquist, 2004). Transgender men are offered voice therapy 
if needed; the effect of testosterone on the vocal folds and satisfaction with the voice has 
recently been studied (Nygren, Nordenskjöld, Arver, & Södersten, 2016). 
 
Hair removal by electrolysis or intense pulsed light (IPL) is also included for transgender 
women (National Board of Health and Welfare, 2015). 
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1.5 LEGAL GENDER RECOGNITION 
Due to the work of Jan Wålinder, Inga Thuwe, and Rolf Luft, Sweden became in 1972 the first 
country in the world where it was possible to legally change gender. The law regulated not only 
legal gender recognition but also permission to undergo gender-affirming genital surgery 
(Wålinder & Thuwe, 1976). 
During the time period relevant to this thesis, the law stated that a person could obtain 
permission for gender-confirming genital surgery and change of legal sex if: 
1. The person since youth had felt that she/he belongs to a sex other than that recorded on the 
birth certificate. 
2. The person had lived for a considerable time in accordance with this new gender role. 
3. The person is anticipated to continue to live in such a gender role. 
4. The person is at least 18 years old, a Swedish citizen, unmarried, and sterile. Not stated in 
the law but implicit due to the sterilization requirement was also a requirement of gender-
affirming genital surgery, i.e., vaginoplasty for transgender women and at least hysterectomy 
for transgender men. 
Gradual changes in praxis have for the last 35 years enabled late onset gender dysphoric 
individuals to be eligible. 
 
Legal changes since 2013 
As of 2013, the requirement of being sterile and unmarried was removed, and it is now 
sufficient to have permanent residency in Sweden. After changes to the law, fertility 
preservation is offered prior to treatment and the implicit requirement for gender-affirming 
genital surgery was also removed. The Discrimination Act protecting against discrimination in 
many areas, including healthcare, now also includes gender identity or expression as a ground 
for discrimination. 
1.6 CLASSIFICATION 
Harry Benjamin suggested in his book The Transsexual Phenomenon a means to classify 
persons with gender identity conflict and or cross-gender expression (Benjamin 1966). For 
assigned males at birth, he identified transvestites of three types: I) pseudo-transvestites, II) 
fetishistic transvestites, and III) true transvestites. He distinguished these from transsexuals of 
three types which he termed type IV) non-surgical transsexuals, V) moderate intensity 
transsexuals, and VI) high intensity transsexuals. Wålinder (1968) developed the work of 
Benjamin. 
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The criteria from Wålinder (1968) and Benjamin (1966) consist of three core criteria for gender 
incongruence/gender dysphoria: 
 
Core criteria for gender incongruence/gender dysphoria 
1. Intrapersonal gender incongruence, a gender identity not in line with the assigned sex at 
birth. 
2. Social gender incongruence, the need for the gender identity to be accepted and confirmed 
by others. 
3. Body dysphoria, with different degrees of avoidance and or repulsion to the physical 
characteristics of the assigned gender at birth. When body dysphoria is severe, there is a need 
and a wish for gender-affirming medical treatment to adjust the physical characteristics in order 
to be more congruent with the gender identity. 
 
The three core criteria for gender incongruence/gender dysphoria with or without distress or 
impairment criteria have formed diagnostic criteria in both ICD (World Health Organization, 
1978, 1992) and DSM (American Psychiatric Association, 1980, 1987, 1994, 2000, 2013). 
 
Subcategorization 
It has long been recognized that persons with gender dysphoria represented a heterogeneous 
group and differed regarding sexual interest, sexual orientation, history of cross-dressing or 
not, and age of onset of gender dysphoria (Benjamin 1966; Fisk, 1974; Hirschfeld, 1923; 
Wålinder, 1967). The different clinical presentations raised the question of whether there were 
different backgrounds and causes of gender incongruence/gender dysphoria. Subcategorization 
was also driven by the need to find the right candidates for gender-affirming treatment and 
especially gender-affirming genital surgery. Who would benefit the most, and not regret the 
procedure (Wålinder, Lundström & Thuwe 1978)? The descriptions and theories around the 
different subcategories have mainly concerned transgender women. Over the years, different 
ways to subcategorize have been proposed. 
 
Subcategorization based on psychodynamic background 
Person and Ovesey suggested two groups, primary and secondary transsexualism (Person & 
Ovesey, 1974a, 1974b). Primary transsexualism was also called “true” (Dolan, 1987) or “core” 
transsexualism (Lundström, Pauly, & Wålinder, 1984). They were described as persons with a 
cross-gender identity since early childhood, a strong repulsion towards their genitals, and 
sexual orientation towards their assigned sex at birth. They had a low libido or were asexual, 
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and had no history of cross-dressing for sexual purposes. Furthermore, they applied for gender-
affirming medical treatment at a young age. Most transgender men were seen as belonging to 
this group, but only some of the transgender women (Landén, 1999). 
The cross-gender identity and gender dysphoria of persons with secondary transsexualism 
started in puberty or later. The libido was normal. They had less or no repulsion towards their 
genitals and their gender dysphoria fluctuated. Secondary transsexualism has been subdivided 
into a condition bordering on transvestism and a condition bordering on homosexuality. The 
group bordering on transvestism had a history of cross-dressing starting around puberty and 
initially linked to sexual purposes. Later on, the sexual excitement diminished and cross-
dressing was more for emotional comfort. They were sexually attracted to women. The group 
bordering on homosexuality were instead sexually attracted to men and had no history of cross-
dressing (Landén, 1999; Lundström, 1981) 
Person and Ovesey (1974a, 1974b) suggested that primary and secondary transsexualism had 
different etiological backgrounds. Secondary transsexualism was seen as a regressive 
phenomenon developed by homosexual or transvestic individuals under conditions of stress. 
Primary transsexualism was different and had another psychodynamic background. 
 
Subcategorization based on sexual orientation 
Wålinder (1967) described in his initial work three groups of transsexualism: homosexual, 
heterosexual, and asexual.  
Blanchard developed that further and introduced a classification based on sexual orientation 
(in relation to assigned sex at birth). He described gender dysphoria of homosexual or non-
homosexual type (Blanchard, 1985, 1989). The homosexual group included both assigned 
males and females at birth who were exclusively attracted to males or females, respectively. 
He defined the other group as non-homosexual. Non-homosexual transgender women were 
seen as having a transvestic disorder or autogynephilia. Autogynephilia denotes the sexual 
attraction assigned men at birth could have towards the thought or image of themselves as a 
woman (Blanchard, 2005; Lawrence, 2011). 
 
Subcategorization based on age of onset for gender dysphoria 
Gender dysphoria can also be subcategorized according to age of onset. The definition of early 
versus late onset varies (Cohen-Kettenis & Pfafflin, 2010; Zucker, Lawrence, & Kreukels, 
2016). Some defined early-onset transsexualism as: “someone aware of transsexual feelings 
before the age of twelve” and late onset as all others (Burns, Farrell, & Brown, 1990; Doorn, 
Poortinga, & Verschoor, 1994; O'Gorman, 1982). The European Network for the Investigation 
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of Gender Incongruence (ENIGI) group has defined early onset as when someone 
retrospectively would have fulfilled the criteria for Gender Identity Disorder for Childhood 
(DSM-IV) (Nieder et al., 2011).  
 
Debate regarding subcategorization 
There has been criticism of both subcategorization per se and the categories used. Age of onset 
has been questioned for not being well defined, not a good predictor for clinical outcome 
studies, or not being useful for studies elucidating causal mechanism (Lawrence, 2010; Smith, 
Junger, Derntl, & Habel, 2015; Zucker et al., 2016). Using sexual orientation as an outcome 
predictor has on the other hand been criticized by Nieder and colleagues (2016) (Nieder, Elaut, 
Richards, & Dekker, 2016), who found a correlation with outcome in only one (Wierckx et al., 
2014) of ten reviewed studies. Nieder and coworkers (2016) also argue that reports have shown 
that sexual orientation per se is fluid and unstable in transgender persons (Auer, Fuss, Hohne, 
Stalla, & Sievers, 2014; Cerwenka et al., 2014). The different typologies of gender dysphoria 
were used to evaluate who would benefit from gender-affirming genital surgery. To be seen as 
early onset and homosexual according to assigned sex at birth were initially necessary to be 
eligible for gender-affirming health care (Fisk, 1974; Wålinder, 1968). This is no longer the 
case, but the fear of not being seen as a candidate for gender-affirming treatment and a 
resistance against subcategorization still exists in the transgender community discourse 
(Stryker, 2008). In a Finnish study on post-medical transition, 44% reported that they falsified 
their story during assessment (Pimenoff & Pfäfflin, 2011). Hence, the reliability of data both 
regarding age of onset and sexual orientation has been questioned (Cohen-Kettenis & Pfafflin, 
2010; Nieder et al., 2016). 
1.7 DIAGNOSES 
The term “diagnosis” is derived from the Greek meaning “through knowledge”, and is the 
identification of an illness or disease. Diseases can be classified on three different levels: 
symptomatic level, pathogenic level, and an etiological level (Wulff, Andur Pedersen, & 
Rosenberg, 1990). The diagnosis of gender dysphoria is so far based on the clinical presentation 
and symptoms (Landén, 1999). The international classification of diseases and related health 
problems (ICD) is a medical classification issued by the World Health Organization (WHO). 
It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social 
circumstances, and external causes of injury or diseases. It is used to classify diseases for 
epidemiologic, statistic, diagnostic, and etiologic purposes (World Health Organization, 1992). 
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ICD 
ICD is updated regularly and the eleventh revision (ICD-11) is scheduled to be published in 
2018 (Reed et al., 2016). A gender dysphoria diagnosis first appeared in ICD-8 (World Health 
Organization, 1967) where it was labeled Transvestitism. The interpretation of this diagnosis 
is unclear and it should be remembered that Hamburger used it when he presented the treatment 
of Christine Joergensen (Drescher, Cohen-Kettenis, & Winter, 2012; Hamburger et al., 1953; 
World Health Organization, 1967). With ICD-9, the spelling was changed to Transvestism and 
defined as a sexual deviation in which sexual pleasure is achieved by dressing in clothes of the 
opposite sex. A new diagnosis also appeared: Trans-sexualism (302.5), probably reflecting the 
growing research following on from Harry Benjamin’s work in 1966 (World Health 
Organization, 1978). ICD-10 included five diagnoses (Table 3) (World Health Organization, 
1992). Dual Role Transvestism and Gender Identity Disorder of Childhood were omitted from 
the Swedish version of ICD-10 in 2009. For an overview of gender dysphoria diagnoses in the 
different revisions of ICD see Table 3. 
Diagnostic criteria for Transsexualism, F64.0, ICD-10 (World Health Organization 1992): 
1. A desire to live and be accepted as a member the opposite sex, usually accompanied by a 
sense of discomfort, or inappropriateness of, with one’s anatomic sex and wish to have 
hormonal treatment and surgery to make one’s body as congruent as possible with the preferred 
sex. 
2. The transsexual identity should have been persistently present for at least 2 years. 
3. It should not be symptom of another mental disorder or associated with any intersex, genetic 
or chromosome abnormality.  
 
DSM 
The Diagnostic and Statistical Manual for Mental Disorders (DSM) issued by the American 
Psychiatric Association (APA) is a parallel diagnostic classification for psychiatric diagnoses, 
mainly used in the United States of America and in some other countries. DSM-III was the first 
version that gained international approval. The idea was to use scientifically or evidenced-
based medical knowledge and define diagnoses with a set of symptom criteria (American 
Psychiatric Association, 1980). DSM is also updated regularly and the fifth version, DSM-5, 
was published in 2013 (American Psychiatric Association, 2013). The criteria for gender 
dysphoria have varied across versions but all revolved around the core criteria of intrapersonal 
gender incongruence, social incongruence, and body dysphoria. DSM-III-R also introduced a 
new diagnosis: Gender Identity Disorder of Adolescence or Adulthood, Nontranssexual Type 
(GIDAANT), reflecting back to Benjamin’s Type IV, non-surgical transsexuals. GIDAANT 
 18 
describes individuals with gender dysphoria who would not benefit from gender-affirming 
genital surgery (American Psychiatric Association, 1987). Table 4 shows an overview of the 
different versions of DSM diagnoses. 
 
Table 3. Gender dysphoria diagnoses in ICD. 
 
Time period 
for use in 
Sweden 
ICD version Chapter: 
Parent category: 
Diagnostic name 
1969-1986 ICD-8 (WHO 1967) Chapter: Psychiatric 
Parent category: Sexual 
deviation 
 
302.3 Transvestitism 
1987-1996 ICD-9 (WHO 1978) Chapter: Psychiatric 
Parent category: Sexual 
deviation 
 
302.3 Transvestism 
302.5 Transgender-sexualism1 
1997-ongoing ICD-10 (WHO 1992) Chapter: Psychiatric 
Parent category: Gender 
Identity Disorder 
F64.0 Transsexualism 
F64.1 Dual role transgendervestism2 
F64.2 Gender Identity Disorder of 
childhood2 
F64.8 Other gender identity disorders 
F64.9 Gender Identity Disorder 
unspecified 
 
2018 planned ICD-11 proposed 
(Reed 2016) 
Chapter: Conditions related to 
sexual health 
Gender incongruence in adolescent or 
adults 
Gender incongruence in children 
1 Not used in Swedish version of ICD 9. 2 Not used in Swedish version of ICD 9 since January 1, 2009. 
 
Table 4. Gender dysphoria diagnoses in DSM. 
 
Year DSM 
version 
Section Diagnostic name Specifiers Exclusion 
criteria 
1980 DSM-III Psychosexual 
disorders 
302.5xTranssexualism 
302.6 Gender Identity Disorder of 
Childhood (GIDC) 
302.85 Atypical gender identity 
disorder 
 
Sexual 
orientation 
Disorder of 
sexual 
development 
/intersex 
Schizophrenia 
1987 DSM-III-R Disorders usually 
first evident in 
infancy, childhood 
or adolescence 
302.50 Transsexualism 
302.60 GIDC 
302.85 Gender Identity Disorder of 
Adolescence or Adulthood, 
Nontranssexual Type (GIDAANT) 
302.85 Gender Identity Disorder Not 
Otherwise Specified (GIDNOS) 
 
Sexual 
orientation 
0 
1994 DSM-IV 
and DSM-
IVTV 
Sexual and gender 
identity disorders 
302.85 Gender Identity Disorder in 
adolescents or adults (GID) 
302.6 GIDC 
302.6 Gender Identity Disorder Not 
Otherwise Specified (GIDNOS) 
 
Attracted 
towards males, 
females, both, 
neither, 
unspecified 
Disorder of 
sexual 
development/ 
intersex for GID 
but not for 
GIDNOS 
2000 DSM-5 Gender dysphoria 302.85 Gender Dysphoria in 
adolescents or adults 
302.6 Gender Dysphoria in children 
302.6 Other specified gender 
dysphoria 
302.6 Unspecified gender dysphoria 
Post-transition 
With or 
without 
disorder of 
sexual 
development  
0 
 
  
  19 
Should gender dysphoria be a diagnosis? 
It has been a subject of debate whether Transsexualism or Gender Dysphoria should be a 
diagnosis, and if so, whether it should be placed within the psychiatric chapter of the 
International Classification of Disease (World Health Organization, 1992) and in DSM 
(American Psychiatric Association, 2013). The first appearance of these diagnoses as 
psychiatric diagnoses in the aforementioned publications (using different terms) may be related 
to the social and medical attitudes at a time when Harry Benjamin started to describe and treat 
transgender persons (Drescher et al., 2012). Whether incongruence with one’s gender is a 
natural variation or pathology, and how the different views may influence discrimination, 
stigma, and access to medical treatment, is well discussed in a paper by Meyer-Bahlburg 
(2010). The tradeoff is to reduce stigma while securing access to health care for those in need, 
since in most countries a diagnosis is needed in order to access gender-affirming medical 
treatment (Drescher, 2013; Reed et al., 2016). In order to secure access to health care, a few 
practitioners who partly followed the pressure of their patients argued for inclusion of a 
diagnosis in DSM-III in the 1970s (Pfäfflin, 2011). There was on the other hand a lot of effort 
made to remove the gender dysphoria diagnosis from DSM-5 in order to reduce stigma 
(Pfäfflin, 2011). The dual ambitions of increasing access to health care while reducing stigma 
and discrimination have been a major focus recently, as reflected in the WHO proposal for the 
next edition of the ICD (ICD-11). It is suggested that the current diagnostic term, 
“Transsexualism” will be replaced with “Gender Incongruence of adolescence and adulthood” 
and be moved from Chapter 5 (Mental and Behavioral chapter) to a new chapter entitled 
“Conditions Related to Sexual Health” (Reed et al., 2016).  
 
Gender incongruence of adolescence and adulthood ICD-11 proposal 
The diagnostic requirements include the continued presence for at least several months of at 
least two of the following: 
1. A strong dislike or discomfort with the primary or secondary sex characteristics due to their 
incongruity with the experienced gender. 
2. A strong desire to be rid of some or all of one’s primary or secondary sex characteristics (or 
in adolescence, anticipated secondary sex characteristics). 
3. A strong desire to have the primary or secondary sex characteristics of the experienced 
gender. 
4. A strong desire to be treated (to live and be accepted) as a person of the experienced gender. 
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The ICD-11 proposal supports the view of many that a diagnosis describing transgender 
individuals should not be part of a psychiatric category but at the same time enable access to 
health care. However, by doing so, it also raises questions concerning the future role of mental 
health professionals in transgender care (Bockting, 2016a; Dhejne, Van Vlerken, Heylens, & 
Arcelus, 2016; Fraser & Knudson, 2017; Selvaggi & Giordano, 2014). Furthermore, a more 
inclusive diagnosis would decrease the possibility of using the diagnosis as a tool for 
epidemiology statistics and in the search for the causes of gender dysphoria (Smith et al., 2015; 
Zucker et al., 2016). 
1.8 EPIDEMIOLOGY 
Incidence denotes the frequency by which new cases of illness, injury, or other health 
conditions occur in a given population during a specified period (Rothman, 2002).  
Prevalence is the number or proportion of cases (numerator) or events among a given 
population (denominator) at a given time (Rothman, 2002). 
Information on incidence, prevalence, and sex ratio of individuals diagnosed with gender 
dysphoria diagnoses is important for planning health services. Knowledge of incidence and 
prevalence for a condition could also be used to formulate and test etiological hypotheses. 
 
Incidence, prevalence, and sex ratio of transsexualism / gender dysphoria 
The incidence, prevalence, and sex ratio of individuals with any of the gender dysphoria 
diagnoses are often calculated based on data collected for individuals in a given area who 
during a specific time period received a diagnosis and/or applied for gender-affirming treatment 
and/or change of legal gender at a clinic or to state authorities. A meta-analysis of 12 studies 
found the overall prevalence of transsexualism to be 1 in 21,739 individuals. If separated by 
gender, the figures were 1 in 14,705 assigned males at birth and 1 in 38,461 assigned females 
at birth. This corresponded to 2.6 transgender women to every transgender man (Arcelus et al., 
2015). Included studies measured help-seeking individuals with a gender dysphoria diagnosis 
or subjects who applied for change of legal gender due to a gender dysphoria diagnosis. Two 
population-based studies have assessed the prevalence for Transsexualism (DSM-III) 
irrespective of help-seeking behavior. They showed a higher prevalence and a reverse sex ratio 
compared to the meta-analysis. In Iceland the lifetime prevalence for transgender men was 
1:500 (0.2%) and zero for transgender women (Stefánsson, Líndal, Björnsson, & 
Guðomundsdóttir, 1991). In Taiwan, the lifetime prevalence for transgender men was 1:250 
(0.4%) in small town areas and 1:1429 (0.07%) in metropolitan areas; for transgender women 
the prevalence was 1:2500 (0.04%) in metropolitan areas (Hwu, Yeh, & Chang, 1989). There 
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were no transgender women outside the metropolitan area. An overview of incidence 
prevalence and sex ratio studies is presented in Table 5. 
 
 
The Swedish incidence, prevalence and sex ratio during the 
period 1960-2010 is addressed in this thesis (Study II). 
 
Swedish studies on incidence and sex ratio of gender dysphoria 
Wålinder (1971) calculated the Swedish incidence and sex ratio of all gender dysphoria 
diagnoses in 1968, 1969, and 1970 by asking psychiatrist colleagues how many patients they 
had and included his own clinic. Since then, the incidence in Sweden has been calculated by 
using the applications for change of legal gender and permission to undergo gender-affirming 
genital surgery to The National Board of Health and Welfare. This could be used as a proxy 
for any gender dysphoria diagnoses since a psychiatric evaluation statement must accompany 
the application to confirm a gender dysphoria diagnosis. The incidence increased from 
0.17/100,000/year between 1972 and 1992, to 0.24/100,000/year between 1992 and 2002 
(Landén, Wålinder, & Lundström, 1996; Olsson & Möller, 2003). The increase was significant 
for the whole group and for transgender women, but not for transgender men. Accordingly, the 
sex ratio changed from 1:1.4 to 1:1.8 in the period 1972-2002 (Olsson & Möller, 2003). The 
mean (SD) age at application for transgender women increased from 32.2 (9.5) years during 
1976-1992 to 36.5 (11.0) years during 1992-2002, but was stable for transgender men during 
the same periods, 29.3 (7.4) and 30.0 (9.4) years, respectively (Olsson & Möller, 2003). 
 
Table 5. Incidence, prevalence, and sex ratio of individuals with a gender dysphoria 
diagnosis in various locations. 
 
Author Location 
 
Year 
or 
time 
period 
Incidence 
/100,000 
/year 
Prevalence  
TM 
Prevalence 
TW 
Sex ratio  
TM:TW 
Diagnosis 
/according to 
Source of 
numerator 
Popu-
lation  
Pauly 
(1968) 
 
USA 1968 NS 1:400,000 1:100,000 1:4 NS Request GCS Total 
Wålinder 
(1968) 
 
Sweden 1965-
1967 
NS 1:103,000 1:37,000 1:2.5 Transsexualism/
Wålinder (1968) 
Survey of 
psychiatrists 
>15 y  
Wålinder 
(1971) 
 
Sweden 1967-
1970 
0.15 total NS NS 1:1 Transsexualism/
Wålinder (1968) 
Referral to 
gender clinic 
>15 y  
Hoenig & 
Kenna 
(1974) 
 
England 
and Wales 
1958-
1968 
0.17-0.26 
total 
1:108,000 1:34,000 1:2.9 Transsexualism/
Wålinder (1968) 
Referral to 
gender clinic 
>15 y  
Sørensen & 
Hertoft 
(1980) 
Denmark 1970-
1977 
0.21 Total 
0.11 TM 
0.31 TW 
NS NS 1:2.8 Transsexualism/ 
Wålinder (1968) 
Request GCS >15 y  
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Ross et al. 
(1981) 
Australia 1976-
1978 
0.58 total 1:150,000 1: 24,000 1:6.1 Transsexualism 
/Wålinder 
(1968) 
Survey of 
psychiatrist 
>15 y  
Sørensen & 
Hertoft 
(1982) 
 
Denmark 1951-
1981 
NS NS NS 1:3.6 Transsexualism/ 
Wålinder (1968) 
Receipt GCS >15 y  
O’Gorman 
(1982) 
 
Northern 
Ireland 
1968-
1981 
NS 1:100,000 1:35,000 1:3 Transsexualism 
/ NS 
Referral to 
gender clinic 
>15 y  
Dixen et al. 
(1984) 
 
USA 1967-
1979 
NS NS NS 1:1.7 NS / NS Request GCS >15 y  
Blanchard 
et al. (1987) 
 
Canada 1980-
1984 
NS NS NS 1:1.7 Gender 
dysphoric/ NS 
Referral to 
gender clinic 
>16 y  
Godlewski 
(1988) 
 
Cracow, 
Poland 
1974-
1980 
NS NS NS 5.5:1 Transsexualism 
/ DSM-III 
Referral to 
gender clinic 
NS 
Eklund et 
al. (1988) 
 
The 
Netherlands 
1976-
1986 
NS 1:4,000 1:8,000 1:3 NS Receipt HT at 
gender clinic 
>15 y  
Tsoi (1988) 
 
Singapore Alive 
1986 
NS 1:8,300 1:2,900 1:3 Transsexualism 
/ DSM-III 
Request GCS >15 y  
Hwu et al. 
(1989) 
Taiwan 1982-
1986 
NS 1:1,250 
metropol. 
area 
1:250 small 
town 
1:1,427 
rural area 
1:2,500 
metropol. 
area 
0 small 
town and 
rural area 
 
10:1 
metropol. 
Transsexualism 
/ DSM-III 
Diagnostic 
Interview 
Schedule (DIS) 
Multistage 
random 
sampling in 
the Taiwanese 
population 
>18 y  
Stefansson 
et al. (1991) 
 
 
 
 
Iceland 1931-
1986 
NS 1:500 0 N/A Transsexualism 
/ DSM-III 
Diagnostic 
Interview 
Schedule (DIS 
505 of the 
birth cohort 
1931 in 
Iceland 
N/A 
Bakker et 
al. (1993) 
 
 
The 
Netherlands 
1986-
1990 
NS 1:30,400 1:11,900 1:2.5 Transsexualism 
/ Wålinder 
(1968) 
Receipt HT 
 
>15 y  
De Cupyere 
et al. (1995) 
 
Belgium 1986-
1994 
NS NS NS 1:1.7 Transsexualism 
/ NS 
Referral to 
gender clinic 
>15 y  
Landén et 
al. (1996) 
 
 
 
 
Sweden 1972-
1992 
0.17 total NS NS 1:1.4 Transsexualism 
/ Wålinder 
(1968), ICD-8-9 
Request for 
GCS and 
change of 
legal gender 
marker 
>15 y  
van 
Kesteren et 
al. (1996) 
 
The 
Netherlands 
1975-
1992 
NS 1:30,400 1:11,900 1:3 Gender 
dysphoric/ NS 
Referral to 
gender clinic 
Total 
Weitze & 
Osburg 
(1996) 
 
 
West 
Germany 
1981-
1990 
0.24 total 1:94,000 1:36,000 1:2.3 NS /NS Request for 
change of 
legal gender 
marker. 
NS 
Wilson et 
al. (1999) 
 
Scotland Circa 
1998 
NS 
 
1:52,100 1:12,800 1:3.8 NS/ NS Receipt HT 
and/or GCS 
>15 y  
Garrels et 
al. (2000) 
 
Germany 1970-
1998 
NS NS NS 1:1.9 NS/ NS Referral to 
gender clinic 
NS 
Olsson & 
Möller 
(2003) 
 
Sweden 1992-
2002 
0.24 total NS NS 1:1.9 Transsexualism 
/ Wålinder 
(1968), ICD-8-
10 
Request for 
SCS and 
change of 
>15 y  
  23 
 
 
legal gender 
marker 
Dulko & 
Imielinski 
(2004) 
 
Poland NS NS NS NS 3.4:1 Transsexualism 
/ NS 
Ns NS 
Smith et al. 
(2005) 
 
The 
Netherlands 
prior 
to 
2003 
NS NS NS 1:1.5 NS/ NS Receipt HT 
and or GCS 
>15 y  
Gomez-Gil 
et al. (2006) 
 
Catalonia 1996-
2004 
0.73 total 
2000-2004 
1:48,100 1:21,000 1:2.6 Transsexualism 
/ ICD-10 
Referral to 
gender clinic 
>15 y  
Pimenoff 
(2006) 
 
Finland 1993-
2002 
NS NS NS 1:1 Transsexualism 
/ ICD-10 
Request for 
castration 
NS 
De Cupyere 
et al. (2007) 
 
Belgium 1985-
2003 
NS 1:33,800 1:12,900 1:2.43 NS/ NS Receipt GCS >15 y  
Veale 
(2008) 
 
New 
Zealand 
1995-
2008 
NS 1:22,700 1:3,600 1:6 NS/ NS Gender 
change in 
passport 
>15 y  
Vujovic et 
al. (2009) 
 
Serbia 1987-
2006 
NS 1:44,053 1:42,918 1:1 GID/  
DSM-IV-TR 
Referral to 
gender clinic 
>18 y  
Meyer zu 
Hoberge 
(2009) 
Germany 1981-
2000 
 
0.34 total 
0.26 TM 
0.41 TW 
1991-2000 
1:32,050 1:18,250 1:1.5 NS/NS Request for 
change of 
legal gender 
marker 
NS 
Gómez Gil 
et al. (2009) 
 
Barcelona, 
Spain 
2000-
2006 
NS NS NS 1:2.24 Transsexualism 
/ ICD-10 
 NS 
Baba et al. 
(2011) 
Japanese 
region 
Hokkaido 
2003-
2010 
NS 1:12,200 1:25,200 2:1 GID or 
transsexualism/
DSM-IV or 
ICD-10 
 
Referral to 
gender clinic 
Total 
Ahmadzad-
Asl et al. 
(2011) 
 
Iran 2002-
2009 
NS 1:136,000 1:145,000 1:0.96 GID / 
DSM-IV-TR 
Referral to 
gender clinic 
15-44 y  
Kreukels et 
al. (2012) 
Amsterdam, 
The 
Netherlands 
2009 NS NS NS 1:2.34 Gender 
dysphoric 
individuals/ N/A 
Referral to 
gender clinic 
>17 y  
Kreukels et 
al. (2012) 
Ghent, 
Belgium 
2009 NS NS NS 1:2.5 Gender 
dysphoric 
individuals/ N/A 
Referral to 
gender clinic 
>16 y  
Kreukels et 
al. (2012) 
Hamburg, 
Germany 
2009 NS NS NS 1.33:1 Gender 
dysphoric 
individuals/ N/A 
Referral to 
gender clinic 
>16 y  
Kreukels et 
al. 2012. 
Oslo, 
Norway 
2009 NS NS NS 1.12:1 Gender 
dysphoric 
individuals/ N/A 
 
Referral to 
gender clinic 
>16 y  
GCS = Gender-confirming surgery; GID = Gender Identity Disorder; GIDNOS = Gender Identity Disorder Not Otherwise 
Specified; GD = Gender Dysphoria; HT = Hormone therapy; N/A = Not applicable; NS = Not stated; TM = Transgender 
men; TW = Transgender women; VHA = Veterans Health Administration; y = years old. 
1.9 CAUSES 
The cause of gender incongruence/gender dysphoria remains unknown. Psychosocial factors 
and parental style were suggested early. 
A growing body of observations indicates that gender dysphoria has a neurodevelopmental 
origin. Different approaches have been used to elucidate if individuals with gender dysphoria 
are different from cisgender individuals with respect to known sex differences between 
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cisgender females and cisgender males, or if any other endocrine or genetic factor predispose 
gender dysphoria. 
It has been argued that there is a risk associated with the study of causal mechanisms of gender 
dysphoria. The same concerns have been raised regarding research trying to elucidate the 
background to sexual orientation. The argument goes that human variance could be 
pathologized, which could increase stigma and discrimination. But studies have in fact showed 
the opposite: people who believed that there was a biological cause to gender dysphoria were 
less transphobic (Landén & Innala, 2000). 
 
The sex-atypical differentiation of the brain hypothesis 
There are known biological differences between cisgender women and men. For example, they 
differ regarding sex chromosomes (XX, XY), primary and secondary sex organs, and on group 
level in height, and brain structures. Men have a larger brain volume even if corrected for body 
size (Lüders, Steinmetz, & Jäncke, 2002; Ruigrok et al., 2014; Rushton & Ankney, 2009). Men 
also differ from women in the proportion of white and grey matter, the central division of the 
bed nucleus of the stria terminalis (BSTc), and the third interstitial nucleus of the anterior 
hypothalamus (INAH3) (Byne et al., 2000; Cosgrove, Mazure, & Staley, 2007; Lüders et al., 
2002). There are also sex differences in brain function and brain chemistry. Cisgender women 
and men differ in aspects such as brain activation during cognitive tasks (Bell, Willson, 
Wilman, Dave, & Silverstone, 2006; Frings et al., 2006) and there are gender-specific 
differences in serotonergic and dopaminergic markers; for an overview see Cosgrave et al. 
(2007). Cisgender men and women have also shown different hypothalamic activation after 
smelling odorous sex hormone-like compounds (4,6-androstadien-3-one (AND) and oestra-
1,3,5(10), 16-tetraen-3-ol (EST)). Dutch studies have shown that transgender women had 
female-typical hypothalamic nuclei (Kruijver et al., 2000; Zhou, Hofman, Gooren, & Swaab, 
1995).     
The sex differentiation of the genitals and the brain is believed to be driven by prenatal sex 
hormones and genetic factors (Davies & Wilkinson, 2006; Hines, 2011). Similar factors are 
believed to be involved in causing incongruence between the sex differentiation of the brain, 
and the sex differentiation of the genitals and phenotype. This is theoretically possible because 
the sex differentiation of the genitals occurs prior to the sex differentiation of the brain (Bao & 
Swaab, 2011; Savic, Garcia-Falgueras, & Swaab, 2010). According to this model, transgender 
women would have an under-masculinized or feminized brain and vice versa. 
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Sex dimorphic neural structures and functions 
Following studies in the Netherlands by Kruijver et al. (2000) showing that untreated 
transgender women had female-typical hypothalamic nuclei, other studies have been carried 
out on sex dimorphic structures, neural structures, and functions. 
In summary, the results are inconsistent. Some studies have shown that hormone-untreated 
transgender women and transgender men neurobiologically resemble the sex congruent with 
their gender identity or position themselves in an intermediate position (Hahn et al., 2015; 
Junger et al., 2014; Junger et al., 2013; Kranz et al., 2014; Lin et al., 2014; Rametti et al. 2011a, 
2011b). Other studies report that transgender women and transgender men resemble their 
assigned sex at birth (Savic & Arver, 2011; Zubiaurre-Elorza et al., 2013). For an overview, 
see Smith et al. (2015). 
 
 
Whether or not transgender women differ from cisgender females and/or males regarding 
cerebral activation on exposure to steroid odorous compounds is examined in Study I. 
 
Sex dimorphic neural function – Pheromones 
Pheromones according to the definition of Karlson and Luscher in (1959) are “substances 
secreted externally by an individual and perceived by an individual of the same species in 
which a specific response is induced, for example a specific form of behavior or process of 
development”. The pheromonal stimulation elicits an unconscious response in contrast to the 
olfactory stimulation that triggers a conscious response. The pheromones have been identified 
in all animals including mammals. Their effect is mediated by the vomeronasal organ (VNO), 
but in some animals, such as pigs and ferrets, they can also be mediated by the olfactory 
pathway (Marazziti et al., 2011; Savic, Berglund, Gulyas, & Roland, 2001) So far, there is not 
enough evidence to confirm whether they exist in humans (Wyatt, 2015). However, two 
substances, 4,6-androstadien-3-one (AND) a testosterone derivate produced in human axillary 
secrete, and estra-1,3,5(10), 16-tetraen-3-ol (EST) a substance similar to estrogen, have been 
suggested as putative candidates for human pheromones (Marazziti et al., 2011; Savic et al., 
2001). In females, the anterior hypothalamus, especially the preoptic area and ventromedial 
nucleus, have been shown to be activated by smelling AND, as measured by regional cerebral 
blood flow (rCBF) with positron emission tomography (PET). EST on the other hand only 
activated the olfactory regions, which were not activated by AND. In males the response was 
contrary, where EST activated hypothalamus more specifically in the dorsomedial and 
paraventricular nucleus and AND activated the olfactory regions (Savic et al., 2001). 
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Homosexual cisgender men also showed a similar activation pattern to heterosexual cisgender 
women (Savic, Berglund, & Lindstrom, 2005).  
 
Genetic factors 
A review of twin studies regarding all gender dysphoria diagnoses found that 39.1% of 
monozygotic male or female twins were concordant with GID, whereas all dizygotic twins 
were discordant (Heylens et al., 2012). This would suggest that genetic factors are important 
for developing of gender incongruence/dysphoria. In search for a candidate gene which could 
be involved in gender dysphoria, polymorphism in genes coding for the biosynthesis or actions 
of sex steroids have been studied. Results are, however, inconclusive regarding associations 
with the androgen receptor, the two estrogen receptors, and cytochrome p450 17A, which 
mediates activities essential for steroid production (Bentz et al., 2008; Fernandez et al., 2014a, 
2014b; Fernandez et al., 2015; Hare et al., 2009; Henningsson et al., 2005; Ujike et al., 2009). 
 
Birth order, sibling ratios 
It has been suggested that feminization in males is due to a maternal immune reaction towards 
a male fetus. This reaction would become stronger after each pregnancy and could cause both 
homosexuality and gender dysphoria in assigned males birth. Birth order and sibling ratio have 
been examined in androphilic transgender women, who were found to be late in birth order and 
have a predominance of brothers (Blanchard, Zucker, Cohen-Kettenis, Gooren, & Bailey, 
1996; Bozkurt, Bozkurt, & Sonmez, 2015; Poasa et al., 2004; Tsoi, Kok, & Long, 1977; 
VanderLaan & Vasey, 2011). However, a study from South Korea found a predominance of 
older sisters (Zucker, Blanchard, Kim, Pae, & Lee, 2007). The results are more conflicting 
regarding transgender men. One study has shown that they were late in birth order (Gómez-Gil 
et al., 2011), but another study found transgender boys to be born earlier than their siblings 
(Zucker, Lightbody, Pecore, Bradley, & Blanchard, 1998), and two studies could not find any 
influence of birth order (Blanchard & Sheridan, 1992; Green, 2000). None of the above studies 
in transgender men found any difference in sibling sex ratio compared with controls. 
 
Psychosocial factors 
Different psychosocial theories have been suggested to explain the origin of gender dysphoria. 
From a psychoanalytic perspective, Person and Ovesey (1974a,b) saw gender identity conflicts 
as a defense mechanism against separation anxiety, early identity formation, and inner 
conflicts. The psychoanalytic treatment should then accordingly be directed towards denial 
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(Person & L. Ovesey, 1974a,b). Socarides (1970) viewed gender dysphoria as a defense action 
against homosexuality. 
Different family dynamics or structures, such as extreme closeness to the mother or an absent 
mother in assigned females, were believed to cause atypical gender development. An absent 
father or a strong parental wish for a child of a specific sex has been proposed to interfere with 
the child’s gender identity development and in turn cause gender incongruence and gender 
dysphoria (Green, 1974; Levine & Lothstein, 1981; Meyer, 1982; Stoller, 1968). No solid 
evidence was found when these hypotheses were tested (Cohen-Kettenis & Gooren, 1999; 
Zucker & Bradley, 1995). Mothers of children with gender dysphoria more often had 
depression and met the criteria for borderline personality disorder (Marantz & Coates, 1991; 
Rekers, Mead, Rosen, & Brigham, 1983). This finding could, however, also be explained by a 
selection bias and that such parents tend to seek help more often (Cohen-Kettenis & Gooren, 
1999). Wallien et al. (2007) could not find elevated psychopathology in parents (Wallien, van 
Goozen, & Cohen-Kettenis, 2007). Different recalled parental rearing styles have also been 
discussed. Transgender men have recalled that both parents were emotionally rejecting, and 
perceived their mothers as more overprotective and dominant compared with non-transgender 
individuals. Transgender women recalled their father being more controlling and critical, and 
their mother being disengaged (Cohen-Kettenis & Gooren, 1999; Parker & Barr, 1982; Simon, 
Zsolt, Fogd, & Czobor, 2011). However, if this is a cause or effect phenomena is still under 
dispute (Simon et al., 2011). 
Later theories have suggested that a combination of specific child and parental factors during 
critical early periods in the child’s life led to gender incongruence/dysphoria: e.g., anxiety in 
the child, feminine appearance in boys, or more masculine appearance in girls, combined with 
parental factors such as lack of boundary setting, fear of male aggression in mothers, or 
psychopathology in parents (Cohen-Kettenis, Owen, Kaijser, Bradley, & Zucker, 2003; 
Marantz & Coates, 1991; Zucker & Bradley, 1995). However, Wallien and coworker (2007, 
2008) could not confirm elevated psychopathology in parents or elevated anxiety in the child 
(Wallien et al., 2007; Wallien, 2008). 
Some authors have suggested that child abuse experiences may be implicated in the etiology 
of gender dysphoria (Devor, 1994; Zucker & Kuksis, 1990), while others have argued that 
sexual minorities are more vulnerable to childhood abuse (Andersen & Blosnich, 2013; Corliss, 
Cochran, & Mays, 2002; Simon et al., 2011). 
John Money proposed that imprinting during the first 2-3 years influences human gender 
identity. He also proposed that rearing a child as a girl or a boy would result in a corresponding 
respective gender identity (Money, Hampson, & Hampson, 1957). He described a pair of male 
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twins, one of whom was accidently castrated during circumcision at the age of 7 months. This 
child was then raised as a girl and, according to initial reports, had a female gender identity 
(Money, 1975). However, long term follow-up revealed that the “girl” experienced a 
problematic puberty as a female and later on transitioned to live as a man (Diamond & 
Sigmundson, 1997). He married and adopted a child but later sadly committed suicide. The 
case indicates that gender identity is unlikely to be influenced through upbringing (Diamond 
& Sigmundson, 1997). 
1.10 MORTALITY 
A large (n =1331) Dutch single center study with a mean of 18.5 years follow-up period has 
shown a 51% higher mortality in transgender women who had been treated with cross-sex 
hormones compared with the general population (Asscheman et al., 2011). The causes of death 
were related to suicide, acquired immune deficiency syndrome, cardiovascular disease, drug 
abuse, and unknown causes. Pulmonary and hematological cancers were elevated. Current, but 
not prior, use of ethinyl estradiol was associated with a threefold increase in death due to 
cardiovascular disease. In contrast, no elevated mortality was seen for transgender men 
(Asscheman et al., 2011). Similar findings have been reported from a large cohort from the 
American Veterans Health Administration, who found a higher suicide rate compared with the 
general population (Blosnich, Brown, Wojcio, Jones, & Bossarte, 2014). A smaller 
retrospective Danish register study (1978-2010) of 104 transgender persons found that 10 
persons (4 transgender men and 6 transgender women) died at a mean age of 53.5 (SD = 7.3) 
and 53 (SD = 7.9) years, respectively (Simonsen, Hald, Kristensen, & Giraldi, 2016a). By 
comparison, life expectancy in Denmark was at the time 78.0 and 81.9 years for males and 
females, respectively. Causes of death included smoking and alcohol-related diseases (n = 4), 
suicide (n = 2), cardiovascular diseases (n = 2), cancer (n = 1), and ulcer (n = 1) (Simonsen et 
al., 2016a,b). Not only deaths due to suicide but also homicide contributed to the mortality. 
Transgender Murder Monitoring (TMM) is a research project by Transgender Europe (TGEU) 
that monitors reported murders of transgender persons in order to increase awareness and honor 
the lives of those who might otherwise be forgotten. TGEU reports a total of 2,264 known 
homicides of transgender and gender-diverse people in 68 countries worldwide between 
January 1, 2008 and September 30, 2016 (Transgender Europe, 2017). 
Study III examined mortality following legal and surgical 
transition. 
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1.11 MENTAL HEALTH 
Mental health has been examined in self-identified gender dysphoric individuals as well as in 
transgender persons with a gender dysphoria diagnosis recruited at transgender health care 
service prior to or following gender-affirming treatment, or in mixed groups pre-treatment and 
post-treatment. A review of studies of adult transgender persons attending different stages of 
treatment of gender-affirming health care at the time of assessment concluded that levels of 
psychopathology and psychiatric morbidity are higher than normative data or controls, but 
improve following gender-affirming treatment (Dhejne, van Vlerken, Heylens, & Arcelus, 
2016). Interestingly, de Vries and coworkers (2011) found that a majority of gender dysphoric 
adolescents did not suffer from psychiatric morbidity (de Vries, Doreleijers, Steensma, & 
Cohen-Kettenis, 2011). The above mentioned review found that the main psychiatric diagnoses 
were depression and anxiety disorders, while other major psychiatric disorders such as 
schizophrenia or bipolar disorder were rare (Dhejne et al., 2016). The results are conflicting 
with regard to gender differences. Some found more psychopathology in transgender women 
(Claes et al., 2015; Duisin et al., 2014; Simon et al 2011) and others found no differences 
between the gender groups (Colizzi et al., 2015; Fisher et al., 2013; Heyelens et al 204a). Some 
studies used cisgender control groups (Auer et al., 2013; Davey, Bouman, Meyer & Arcelus, 
2014; Duisin et al., 2014) compared with normative data (Gomez-Gil, Vidal-Hagemeijer, & 
Salamero, 2008; Haraldsen & Dahl, 2000; Kersting et al., 2003; Kim et al., 2006; Simon et al., 
2011), or compared hormone treated or non-hormone treated transgender groups (Fisher et al., 
2014; Gorin-Lazard et al., 2013), but most used no comparison group. Mental health outcomes 
were most often evaluated with self-report measures of psychological or psychiatric symptoms, 
e.g., Symptom Check List-90 (SCL-90) and Hospital Anxiety and Depression Scale (HADS). 
Few studies examined participants with gender dysphoria diagnoses using structured diagnostic 
interviews such as Mini International Neuropsychiatric Interview (MINI) or Structured 
Clinical Interview for DSM-IV-Axis I Disorders (SCID-I). Most of these found elevated 
psychiatric morbidity, mainly affective and anxiety disorders, compared with the general 
population (Heylens et al., 2014a; Mazaheri Meybodi, Hajebi, & Ghanbari Jolfaei, 2014a). 
However, two studies report rates of current psychiatric morbidity to be similar to the general 
population (Colizzi, Costa, & Todarello, 2014; Hoshiai et al., 2010). Though Colizzi et al. 
(2014) excluded participants with severe psychiatric morbidity, Hoshiani et al. (2010) found 
that 76% had any lifetime suicide attempt or self-injury. A Swedish study examined studied 19 
transgender persons all diagnosed with Transsexualism (DSM-III-R), almost half received an 
Axis 1 disorder diagnosis (Bodlund, Kullgren, Sundbom, &Höjerback 1993). Landén, 
Wålinder & Lundström (1998a) examined a national cohort of transgender persons when they 
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applied for legal and surgical sex reassignment in the time frame 1972-1992 in Sweden. In this 
cohort, more than a third had received psychiatric treatment and 20% had a history of suicide 
attempts (Landén et al., 1998a). A Danish register study of 104 transgender persons who had 
undergone legal and surgical sex reassignment reported that 28% had a psychiatric diagnoses 
registered before and 22% after transition, while only 6.7% were registered both before and 
after transition (Simonsen et al. 2016b).  
Regarding personality disorder the prevalence rates range from 4.3% (Fisher et al., 2013) to 
81.4% (Mazaheri Meybodi, Hajebi, & Ghanbari Jolfaei, 2014b). The type of personality 
disorder varied from predominately cluster B (Hepp, Kraemer, Schnyder, Miller, & Delsignore, 
2005; Madeddu, Prunas, & Hartmann, 2009; Mazaheri Meybodi et al., 2014b) to cluster C 
(Heylens et al., 2014a). In Sweden, Bodlund, Kullgren, Sundbom and Höjerback (1993) found 
that 26% fulfilled the criteria for at least one personality disorder, as compared with 17% 
among health care professional controls. It was common to have more than one personality 
disorder, and cluster B (i.e., borderline, histrionic, antisocial, and narcissistic personality 
disorders) was more common compared to clusters of the other personality disorders. For an 
overview of psychiatric morbidity in the transgender population 2000-2015, see Table 15 in 
Appendix. 
Study III and IV examined psychiatric morbidity following 
legal and surgical transition. 
 
1.12 SUICIDE ATTEMPTS AND NON-SUICIDAL SELF-INJURY 
Corresponding to the high numbers of death by suicide, lifetime suicide attempts in self-
identified or individuals with a diagnosis of gender dysphoria are high. In pre-treatment or in 
mixed pre-treatment and post-treatment groups, around 30% have attempted suicide 
(Marshall, Claes, Bouman, Witcomb, & Arcelus, 2016; Zucker et al., 2016). Most studies 
report no gender differences although Landén et al. (1998a) found suicide attempts to be 
more common in transgender women (23% as compared with 14% in transgender men). A 
reduction of suicide attempts from 29% pre-treatment to 5% post gender-affirming treatment 
was reported by Cuypere et al. (2006) but the reduction did not account for time at risk. Non-
suicidal self-injury is less studied. Claes et al. (2015) and Davey, Arcelus, Meyer, & Bouman 
(2016) found a prevalence rate of 19-36% and that non-suicidal self-injury was more 
common compared with cisgender controls (Claes et al., 2015; Davey et al., 2016). Regarding 
gender differences non-suicidal self-injury seems to be more common among transgender 
  31 
men compared with transgender women (Claes et al., 2015; Davey et al., 2016; Skagerberg, 
Parkinson, & Carmichael, 2013). 
1.13 CAUSES OF MENTAL HEALTH ISSUES 
The reasons for high psychiatric morbidity in transgender persons both before and after gender-
affirming health care are unclear. Childhood adversities such as physical, emotional, and sexual 
abuse have been shown to predict psychiatric morbidity (Björkenstam, Burström, Vinnerljung, 
& Kosidou 2016; Chen et al., 2010; Hovens et al., 2010; Kessler et al., 2010), suicide attempts, 
and suicide in the general population (Bruffaerts et al., 2010; Evans, Hawton, & Rodham, 2005; 
Jokinen, 2015). Childhood advertises is reported to be more common in sexual minority groups 
(Corliss, et al, 2002), and could thus be a possible explanation also in the transgender group. 
Minority stress and gender-related abuse in adulthood have also been put forward as reasons 
for psychiatric ill health in transgender persons (Meyer, 2003). Meyer (2003) describes that the 
stress may be both distal processes as rejection and discrimination and proximal processes 
where the stress results from internalized prejudice. That minority stress and gender related 
abuse in the transgender population is associated with increased mental health problems have 
been reported (Bockting et al., 2013; Claes et al., 2015; Clements-Nolle, Marx, & Katz, 2006; 
Nuttbrock et al., 2012; Nuttbrock et al.,2014; Reisner et al., 2016c). 
 
Vulnerability 
Adult stressful life events 
The transgender group as a whole is vulnerable with numerous reports regarding 
discrimination, harassment, physical abuse, sexual abuse and difficulties accessing health 
services or negative health care encounters (Lombardi Wilchins, Priesing, & Maluf, 2002; 
Prunas et al., 2016; Public Health Agency of Sweden, 2015, von Vogelsang et al., 2016; Zeluf 
et al., 2016). 
 
Childhood adversities 
Few studies have surveyed the prevalence of childhood adversities (CA) in individuals 
applying for gender-affirming health care or diagnosed with a gender dysphoria diagnosis. One 
study found that transgender women reported a higher prevalence of emotional abuse and 
neglect in comparison with psychiatric inpatients (Kersting et al., 2003), and transgender 
women maltreated in childhood displayed worsened mental health as measured by SCL-90 
(Bandini et al., 2011). Among self-identified transgender men, 60% reported to have 
experienced severe child abuse (Devor, 1994). A Hungarian study found that gender dysphoric 
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individuals who sought gender-affirming treatment had experienced more maternal 
dominance, emotional abuse, and neglect during childhood compared with controls. Assigned 
males at birth were also more exposed to disengaged mothers and more emotional neglect or 
criticism from their fathers (Simon et al., 2011). Finally, in a sample of transgender women 
and transgender men seeking evaluation prior to gender-affirming treatment, 77% reported 
being verbally abused, 58% were made to feel guilty by their parents, and 55% reported to be 
victims of childhood sexual abuse (Gehring & Knudson, 2005). 
 
Whether childhood maltreatment, adult victimization, and/or 
sexual abuse were associated with psychiatric morbidity was 
addressed in Study IV. 
 
Criminality 
Criminality leading to prosecution was reported by 6/99 (6.1%) of transgender men and 13/134 
(9.7%) of transgender women at the application of legal and surgical reassignment (Landén et 
al., 1998a) and incarceration was more common among combat veterans with a gender 
dysphoria diagnosis compared with those without such a diagnosis (Brown & Jones, 2015). 
1.14 OUTCOME 
The aim of gender-confirmation treatment is to ease gender dysphoria and for the individual to 
become as gender congruent (defined by the individual themselves) as possible. Thus the 
primary outcome measures are gender congruence, reduced gender dysphoria, global clinical 
impression improvement, quality of life, and not regretting the procedure. 
Reduced psychiatric comorbidity and better psychological well-being are often used as 
secondary outcome measures. Moreover, it is important to monitor the safety and potential side 
effects of gender-affirming treatment. 
A meta-analysis of outcome studies of post cross-sex hormone treatment up to 2005 concluded 
that approximately 80% experienced improvement in terms of gender dysphoria and quality of 
life (Murad et al., 2010). However, the quality of studies was low, with many lost to follow-up 
and a lack of control subjects. Later longitudinal studies and retrospective studies post gender-
affirming treatment of participants diagnosed with any of the gender dysphoria diagnoses have 
confirmed the results, finding subjective improvement, less gender dysphoria, no or few 
regrets, and less psychopathological symptoms (Colizzi, et al.,, 2013; Colizzi, et al., 2014; De 
Cuypere et al., 2006; de Vries et al., 2014; Heylens et al., 2014b; Johansson, Sundbom, 
Höjerback, & Bodlund, 2010; Manieri et al., 2014; Pimenoff & Pfäfflin, 2011; Ruppin & 
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Pfafflin, 2015; Udeze, Abdelmawla, Khoosal, & Terry, 2008). It should be noted that four of 
the studies had a short follow-up time ranging from 3 to 12 months (Colizzi et al., 2013, 2014; 
Heylens et al., 2014b; Udenze et al., 2008). The studies with longer follow-up time (5-13 years) 
are on the other hand flawed by high dropout rates (16-49%), and relatively small samples (32-
71 participants) (Johansson et al., 2010; Pimenhoff & Pfäfflin 2011; Rupper &Pfäfflin 2015; 
De Cuypere et al., 2006.). Table 6 presents an overview of Swedish follow-up studies. 
 
Table 6. Swedish outcome studies of legal and medical transition. 
 
Author Study 
design 
Time 
period 
Parti-
cipants 
Response 
rate % 
 
Follow-up 
time 
mean, 
(min-max) 
in years 
Suicide 
/deceased 
of other 
reasons 
Regret 
% 
Patient 
evaluation 
improved or 
unchanged 
% 
Clinician 
evaluation 
 improved, 
unchanged or 
worsened % 
Wålinder & 
Thuwe 
(1975) 
 
P 1962-
1974 
24 
(13 TW, 
11 TM) 
100 ≥3  1 All 8 
TW 15 
 
NS 79 
Lindemalm 
et al.  (1986) 
  
C-S 1979 13 TW 
 
87 
 
12  
(6-25) 
1 TW 31 NS 69 
Bodlund et 
al. (1996) 
P NS 19 
(10 TW, 
9 TM) 
 
100 5  0 All 5 
TW 10 
 
+  63 
+- 32 
 
+ 68 
-  16 
 
Eldh et al. 
(1997) 
 
 
C-S 1965-
1995 
90 
(50 TW, 
40 TW) 
66 5.8  
(0.5-30) 
3 /3 
 
All 4 
TW 4 
TM 5 
+  86 overall  
satisfied 
Landén et al. 
(1998b) 
 
 
R  205 
(115 TW, 
90 TM) 
100 7.4 
(NS) 
N/A All 4 
TW 4 
TM 3 
N/A N/A 
Johansson et 
al. ( 2010) 
 
P NS 42 
(25 TW, 
17 TM) 
70 9.0  
(4-16) 
0/1 0 +  95 + TW 72, TM 47 
+- TW 20, TM 30 
C-S = cross-sectional; N/A = not applicable; NS = not stated; P = prospective, R = retrospective; TM = Transgender men; 
TW = Transgender women; + = improved; +- = unchanged; - = worsened. 
 
Regrets to the procedure 
Regretting having undergone legal and medical transition is a dire outcome. Since the start of 
gender-affirming treatment, this has constantly been on the agenda: how to avoid regrets, and 
how to best identify risk factors for regret. Gender-affirming treatment is mostly performed in 
steps. This gives the individual time to evaluate each step before undergoing irreversible genital 
surgery. During this time, there are individuals who stop medical transition and reverse their 
gender role to their assigned sex at birth. It is not known how common these types of regrets 
are. In the literature, regret is either measured as legal regret applications or by explicitly asking 
persons if they regret the procedure or wish to re-transition. In early Swedish follow-up studies 
(3-12 years mean follow-up time), the regret rate was 8-31% (Lindemalm, Körlin, & 
Uddenberg, 1986; Lindemalm, Körlin, & Uddenberg, 1987; Wålinder & Thuwe, 1975). 
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Landén, Wålinder, Hambert, & Lundström (1998b) assessed legal regret applications to the 
National Board of Health and Welfare from 1973-1996 and found a regret rate of 3.8% (4.3% 
transgender women and 3.25% transgender men). In Germany and the Netherlands, regrets 
rates of 0.4-0.6% have been reported (Meyer zu Hoberge, 2009; van Kesteren, Asscheman, 
Megens, & Gooren, 1997; Weitze & Osburg, 1996). 
 
Postoperative regrets were examined in Study II 
 
Prognostic outcome factors 
Various positive prognostic factors regarding outcomes after legal and medical transition have 
been suggested.  
Good family support, and being in a relation (Bodlund & Kullgren, 1996; Landén et al., 1998b; 
Wålinder et al, 1978), good surgical result (De Cuypere et al., 2005; Eldh et al., 1997; 
Lawrence, 2003; Lundström et al., 1984; Pfäfflin, & Junge, 1992; Ross & Need, 1989),  
successful social transition, good diagnostics and proper care (Pfäfflin & Junge ,1992; Eldh et 
al., 1997) being read as and perceived by others in accordance with experienced gender identity 
(De Cuypere et al., 2006; Eldh et al., 1997; Ross & Need, 1989), being assigned female at birth 
(Smith, van Goozen, Kuiper, & Cohen-Kettenis, 2005; Blanchard, 1989; Pauly, 1981; Bodlund 
& Kullgren, 1996; Wålinder et al., 1978; Wålinder & Thuwe, 1975, Landén et al., 1998b),  
and positive self-image (Bodlund & Kullgren, 1996) have been identified with fewer regrets 
and/or positive outcomes of legal and medical transition. Some studies identified older age, 
secondary transsexualism, late onset or gynephilic transgender women as risk factors (Landén 
et al., 1998b; Blanchard et al., 1987; De Cuypere et al., 2006; Eldh et al., 1997; Lindemalm et 
al., 1987; Lothstein, 1979; Pfäfflin & Junge, 1992; Smith et al., 2005; Sørensen, 1981; 
Wålinder et al., 1978). Later studies have not confirmed any differences in outcome related to 
gender, sexual orientation or age of onset (Colizzi et al., 2013; Colizzi et al., 2015; Gorin-
Lazard et al., 2013; Heylens, et al., 2014; Johansson et al., 2010; Ruppin & Pfäfflin, 2015). 
Prior psychiatric morbidity, personality disorder, or social instability has also been seen as 
predictors for regrets or suboptimal outcomes (Bodlund & Kullgren, 1996; Landén et al., 
1998b; Wålinder et al., 1978). However, Landén et al., (1998b) found that a history of psychotic 
disorders but not psychiatric treatment per se was a negative predictor. The co-occurrence of a 
psychotic disorder has been seen as a risk factor due to diagnostic difficulties, difficulties to 
assess expectations, and that the hormone treatment might impair the psychotic symptoms 
(Borras, Huguelet, & Eytan, 2007; Landén, 1999). Intrestingly, Meijer and coworkers (2017) 
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recently reported of four individuals with gender dysphoria and schizophrenia related 
diagnoses who received gender-affirming treatment. At follow-up at least three years since start 
of hormone treatment, satisfaction rate was high and stabilization of psychotic symptoms was 
seen (Meijer, Eeckhout, van Vlerken, & de Vries, 2017).  
Interestingly one study compared patients who had been compliant to their treatment plan and 
found no differences in outcome (Pimenoff & Pfäfflin, 2011).Whether high sexual activity 
prior to treatment is negative as reported by Wålinder et al. (1978) or low sexual activity is 
negative as reported by Lindemalm et al. (1987) has not been evaluated in other studies. 
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2 AIMS OF THE THESIS 
The overall aim of this thesis was to explore the neurobiological underpinnings of gender 
dysphoria, study secular trends in incidence, and study health and mortality following gender-
affirming health care. 
2.1 SPECIFIC AIMS 
The specific aims and research questions were: 
 
Study I 
To examine whether gynephilic transgender women (assigned male at birth, female identified, 
attracted to women) differ from cisgender female and male controls regarding cerebral 
activation when exposed to odorous steroids prior to hormone treatment. 
 
Study II 
To describe the prevalence and incidence of applications for change of legal sex, genital 
surgery, and regret over the procedure during 1960-2010. Additional aims were to examine 
changes over time with respect to sex ratio, applicants’ age, average time elapsed from first 
visit to being granted a new legal gender, reasons for application rejection, and number of 
individuals choosing surgical treatment abroad. 
 
Study III 
To analyze long-term mortality, psychiatric morbidity, and criminality after legal gender 
reassignment and gender-affirming genital surgery 1973-2003 in a nationwide cohort study. 
 
Study IV 
To study the outcomes of gender-affirming health care and legal gender transition in terms of 
gender congruence, global improvement, and psychiatric morbidity. Additional aims were to 
evaluate whether childhood adversities and adult stressful life events predicted psychiatric 
morbidity post transition. 
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3 METHODS 
The studies included in this thesis used different designs, populations, data and statistical 
methods depending on the research question (Table 7). 
 
Table 7. Summary of aims and methods applied in Study I-IV. 
 
Study Research question / study 
aim 
Design /time 
period 
Study population/ diagnostic 
manual/ stage of transition 
Data 
I Do transgender women differ 
from cisgender controls 
regarding cerebral activation if 
exposed to steroid odorous 
compounds? 
 
Experimental 
2001-2006 
 
12 gynephilic TW/ 
 
ICD-10/ 
 
pre gender-affirming treatment 
PET images of cRBF 
II Incidence of applications for 
change of legal sex and 
permission for gender-
affirming genital surgery, 
including postoperative regret 
 
Descriptive 
1960-2010 
 
767 (289 TM, 478 TW)/ 
 
Wålinder, ICD8-10/ 
 
application for legal and genital 
surgical transition 
 
Applications for legal 
and surgical 
reassignment 
III Long-term mortality, 
psychiatric morbidity, after 
legal reassignment and gender-
affirming genital surgery 
 
A population-
based, 
matched case 
cohort study 
1973-2010 
324 (133 TM, 191 TW)/ 
 
ICD8-10/ 
 
post legal and surgical transition 
 
Linked data from 
Swedish registers 
IV Outcome post transition 
regarding gender congruence, 
psychiatric morbidity, and its 
relation to adversities in 
childhood and adult life 
 
Cross-
sectional 
follow-up 
study 
2006-2009 
65 (16 men [AFAB], 
49 women [AMAB])/ 
 
ICD8-10/ 
 
post legal and surgical transition 
Self-constructed 
questionnaire, GCI-I, 
MINI, ASRS, AQ, 
AUDIT 
 
AFAB = assigned female at birth; AMAB = assigned male at birth; ASRS = Adult Self-Report Scale Screener; AQ = The 
Autism Spectrum Quotient; AUDIT = Alcohol Use Disorders Identification Test; CGI-I = Clinical Global Impression 
Improvement; cRBF = cerebral regional blood flow; MINI = Mini International Neuropsychiatric Interview; PET = positron 
emission tomography; TM = transgender men; TW = transgender women. 
3.1 STUDY I 
In Study I, we investigated whether transgender women differed from cisgender female and 
male controls regarding cerebral activation when exposed to odorous steroids prior to hormone 
treatment. We performed functional neuroimaging and used positron emission tomography 
(PET) to characterize cerebral activation through regional cerebral blood flow (rCBF) patterns. 
 
Participants and controls 
Twelve gynephilic transgender women, diagnosed with Transsexualism (F64.0, ICD-10) 
during 2001-2006 were enrolled. The sampling procedure was opportunistic.  
The diagnostic evaluation was made by transgender-experienced psychiatrists and 
psychologists at the Gender Team in Stockholm. Age at onset of gender dysphoria was prior 
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to 7 years for all except for one participant who reported debut at puberty. Sexual orientation 
was assessed with a modified Kinsey scale (0 = only heterosexual behavior to 6 = only 
homosexual behavior). It was explained to the participants that the scale was devised for 
cisgender persons and they were asked to rate themselves according with their gender assigned 
sex at birth. Nine participants scored between 0-2 on the Kinsey scale (Kinsey & Martin, 1948). 
Three participants had not yet had a sexual relationship, but all reported gynephilic sexual 
attraction and were thus classified as gynephilic.  
All participants were unmedicated. No participants had received hormonal treatment with sex 
steroids, and blood analyses confirmed no current use of hormonal treatment.  
The controls were 12 heterosexual, (scoring zero at the Kinsey scale) cisgender females and 12 
heterosexual cisgender males. The cisgender male controls were somewhat younger than the 
other two groups but otherwise the groups were comparable with respect to age and education 
level (Table 8). 
 
Table 8. Age and length of education of participants and controls. 
 
 Transgender 
women 
Cisgender female 
controls 
Cisgender male 
controls 
Mean (SD) age, years 32 (8) 33(6) 26 (2) 
Mean (SD) length of education, years 12 (3) 13 (2) 13 (2) 
 
Pet and MRI experiments 
The experiments were carried out during the period 2001-2006 at Karolinska PET center by 
the same personnel, at the same time of day, with a standardized room temperature and air 
pressure. The procedure included structural magnetic resonance imaging (MRI) scans and 
functional PET images measuring rCBF with 15O H2O. The odorous compounds used for 
passive smelling during the activation condition consisted of 4,6-androstadien-3-one (AND), 
estra-1,3,5(10),16-tetraen-3-ol (EST), and four different common odors (OO), which consisted 
of lavender oil, cedar oil, eugenol, and butanol. During the PET experiment, all of the stimuli 
were presented in glass bottles at a distance of 10 mm from the nose. AND and EST were 
presented in crystalline and odorous form (200 mg, Steraloids, Newport, RI). Lavender oil, 
cedar oil, and eugenol were undiluted. The butanol solution had a concentration of 10%. 
The activation condition consisted of passive smelling of AND, EST, and OO measured as 
alterations in rCBF patterns. Measurements were made at baseline (= smelling of odorless room 
air [AIR]) and during three stimulus conditions (= smelling AND, EST and OO). In total, there 
were twelve scans per person. After the scans the participants were presented with the odorants 
again and asked to rate the pleasantness, irritability, intensity, and familiarity using a 100 mm 
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visual analogue scale ranging from “very pleasant” to “very unpleasant”, respectively. PET and 
MRI images were registered into a common space and spatially filtered in order to improve the 
signal in both structural and functional image content. Significant activations were determined 
using the Statistical Parametric Mapping software (SPM99, Wellcome Foundation, London, 
UK) (Frackowiak, 2004; Friston, Holmes, & Worsley, 1999; Friston, Holmes, Poline, Price, & 
Frith, 1996). In order to locate the areas of activation in the hypothalamus, we used the 
Schaltenbrant’s Atlas (Schaltenbrand & Bailey, 1959) after translation of the Talairach’s 
coordinates (Talairach & Tournoux, 1988). 
 
Statistical analyses 
We performed analyses at the whole-brain level and at the regional level of the hypothalamus, 
in order to define the spatial extent of how AND and EST activated the brain in each group, 
and to detect between-group differences and similarities. Broadly, three types of statistical 
analyses were performed in SPM99. The analyses pertained to within-group activations, 
between-group activations, and common activations across groups. Cluster-based statistics 
with correction for multiple comparisons at cluster level were used in the analyses, p<0.05 
cluster correction.  
3.2 STUDY II 
In Study II, we examined applications for change of legal sex, and permission for genital 
surgery, as well as postoperative regret. All applications to the National Board of Health and 
Welfare from 1960-2010 were reviewed. Files from January 1, 2011 to June 30, 2011 were 
also analyzed in order to determine whether or not applications were approved. 
 
Incidence was calculated and stratified for four periods between 1972 and 2010. The means of 
the total Swedish population over 17 years of age for the first and the last year of the 10-year 
intervals were used for incidence calculations (Sweden Statistics, 2012). 
 
Prevalence was calculated based on all persons who ever applied for a new legal gender with 
the assumption that all were alive during the study period. 
 
The regret rate was estimated by dividing the number of sex-reassigned individuals who later 
applied for reversal to their original sex with the total number of individuals who received a 
new legal gender. The data were stratified in 10-year time periods. 
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Statistical analyses 
For descriptive statistics mean (SD) and median (min-max) were calculated. Dichotomous data 
were analyzed with Chi-2 or Fisher’s exact test, as appropriate. Results were defined 
statistically significant if the p-value was < 0.0001. 
All tables and statistical analyses were generated in the software package R: A Language and 
Environment for statistical computing. R Core Team. 
3.3 STUDY III 
In Study III, we explored long-term mortality and psychiatric morbidity following sex 
reassignment in a nation-wide cohort study (1973-2003). The study population and outcomes 
were identified by linking several Swedish national registers. Table 3.1.3.2 presents an 
overview of the registers used. 
 
Participants 
Definition and identification of cases 
A person was defined as case exposed to legal and surgical gender reassignment if two criteria 
were met: 
1. at least one inpatient admission with a gender dysphoria diagnosis without any concomitant 
psychiatric diagnosis in the Hospital Discharge Register, and 
2. at least one discrepancy between the sex variable in the Medical Birth Register (from 1973 
and onwards) or the National Censuses, and the latest sex designation in the Total Population 
Register 
The first criterion was employed to capture hospitalization for sex reassignment surgery and 
served to secure the diagnosis and provide a time point for sex reassignment surgery. The 
second criterion was used to ensure that the person went through all steps in sex reassignment 
and eventually changed sex legally. Using these criteria, a total of 804 patients with Gender 
Identity Disorder were identified, of whom 324 displayed a shift in the sex variable during the 
period 1973-2003. The remaining 480 persons that did not shift gender variable comprised 
persons who either did not apply, or were not approved, for gender-affirming genital surgery. 
Moreover, the ICD-9 code 302 is a non-specific code for sexual disorders. Hence, this group 
might also comprise persons hospitalized for sexual disorders other than a gender dysphoria 
diagnosis. These 480 cases were therefore omitted from further analyses. 
 
Start of follow-up 
Start of follow-up was chosen as the estimated date of legal sex reassignment. 
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Definition and identification of population-based controls (unexposed group) 
A person was defined as unexposed if there were no discrepancies in sex designation across 
the Censuses, Medical Birth, and Total Population registers and no gender identity disorder 
diagnosis was recorded in the Hospital Discharge Register. Two groups of 10 unexposed 
controls for each case were matched for birth year and for sex (one group for assigned sex at 
birth, and one group for reassigned sex). The controls had to be alive and residing in Sweden 
at the estimated sex reassignment date of the index person. 
 
Measurements 
The outcomes and covariates of interest were taken from Swedish registers. Table 9 describes 
the outcome measures, covariates, and corresponding registers. Each individual could 
contribute with several outcomes but only one event per outcome. 
 
Statistical analyses 
Each individual contributed person-time from study entry (for exposed: date of sex 
reassignment; for unexposed: date of sex reassignment of matched case) until date of outcome 
event, death, emigration, or end of study period (December 31, 2003), whichever came first. 
The association between exposure (sex reassignment) and outcome (mortality, morbidity, 
crime) was measured by hazard ratios (HR) with 95% CI, taking follow-up time into account. 
HRs were estimated from proportional hazard regression models, stratified on matched sets 
(1:10) to account for the matching by sex, age, and calendar time (birth year). Crude HRs 
(though adjusted for sex and age through matching) and confounder-adjusted HRs (aHRs) 
were presented for all outcomes. 
The two potential confounders, immigrant status (Yes/No) and history of severe psychiatric 
morbidity (Yes/No) prior to sex reassignment, were chosen based on previous research 
(Bodlund & Kullgren, 1996; Landén et al., 1998a). Gender-separated analyses were 
performed and a Kaplan-Meier survival plot graphically illustrates the survival of the sex-
reassigned cohort and matched controls (all-cause mortality) over time. The significance 
level was set at p-value < 0.05 (all tests were two-sided). The data were analyzed using SAS 
version 9.1 (SAS Institute Inc., Cary, NC, USA). 
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Table 9. Outcome measures, definitions/ICD codes and corresponding registers. 
 
Outcome 
measures 
 Register Definitions/ICD codes 
All causes 
of mortality 
 Cause of Death Register 
(CDR) 
Registered as deceased 
 
 Death by definite/uncertain 
suicide 
Cause of Death Register 
(CDR) 
ICD-8 codes and ICD-9 codes E950-E959 and E980-
E989 
ICD-10 codes X60-X84 and Y10-Y34 
 Death by cardiovascular disease Cause of Death Register 
(CDR) 
ICD-8 codes 390-458 
ICD-9 codes 390-459 
ICD-10 codes I00-I99 
 Death by tumor Cause of Death Register 
(CDR) 
ICD-8 codes and ICD-9 codes 140-239 
ICD-10 codes C00-D48 
Any inward 
care for 
   
 Any psychiatric disorder (gender 
dysphoria diagnosis excluded) 
The Hospital Discharge 
Register (HDR) 
ICD-8 codes 290-301 and 303-315 
ICD-9 codes 290-301 and 303-319 
ICD-10 codes F00-F63 and F65-F99 
 Alcohol/substance abuse The Hospital Discharge 
Register (HDR) 
ICD-8 codes 303-304 
ICD-9 codes 303-305, tobacco use disorder excluded 
ICD-10 codes F10-F16 and F18-F19, x5 excluded 
 Definite /uncertain suicide 
attempt 
The Hospital Discharge 
Register (HDR) 
ICD-8 and ICD-9 codes E950-E959, E980-989 
ICD-10 codes X60-X84, Y10-34 
 Accidents The Hospital Discharge 
Register (HDR) 
ICD-8 and ICD-9 codes E800-E929 
ICD-10 codes V01-X59 
Convictions    
 Any criminal conviction The Crime Register 
(CR) 
Any criminal conviction in the CR 
 Any violent conviction 
 
The Crime Register 
(CR) 
Any violent conviction was defined as homicide, 
aggravated assault and assaults, robbery, threatening 
behavior, harassment, arson or any sexual offence, in 
the CR 
 
Covariates 
 
   
Severe 
psychiatric 
morbidity 
 The Hospital Discharge 
Register (HDR) 
Any psychiatric morbidity excluding dementia and 
organic psychiatric symptoms, tobacco use, sleeping 
disorders, sexual dysfunctions, postpartum conditions, 
habit and impulse disorders. 
ICD-8 codes 291, 295-301, 303-304 and 307 
ICD-9 codes 291-292, 295-298, 300-301, 303-305 
(tobacco use disorder excluded), 307.1, 307.5, 308-
309 and 311 
ICD-10 codes F10-F16, F18-F25, F28-F45, F48, F50 
and F60-F62. 
Immigrant 
status 
 Total Population 
Register (TPR) 
Defined as individuals born abroad 
 
3.4 STUDY IV 
In Study IV, we examined outcomes following medical and legal gender transition (mean (SD) 
follow-up time 7.2 (7.3) years) through individual interviews of 16 men (assigned female at 
birth) and 49 women (assigned male at birth). 
 
Participants 
Individuals in Sweden who had undergone gender-affirming health care and had changed 
their legal gender status at least 9 months prior to the examination were invited to participate 
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in this study during 2006-2010. A convenience sample was recruited via transgender 
organizations and transgender health care units in Sweden. Figure 1 outlines the study 
population. 
Individuals in Sweden who had undergone gender-affirming health care and had changed 
their legal gender status at least 9 months prior to the examination were invited to participate 
in this study during 2006-2010. A convenience sample was recruited via transgender 
organizations and transgender health care units in Sweden. Figure 1 outlines the study 
population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of study population. 1 Men = individuals assigned female at birth but 
who identify as males and have been surgically and legally reassigned as men. 2 Women = 
individuals assigned male at birth but who identify as females and have been surgically and 
legally reassigned as women. 
  
586 individuals with new legal sex 
up to 2009 
220 men (assigned female at birth) 
366 women (assigned male at birth) 
90 volunteered  
25 men 1 
63 women 2 
2 retransitions 
(regret) 
2 Dropouts 
 Withdrew their consent during the study  
n = 2 (2 women 2)  
15 Declined  
 Declined due to time issues, somatic 
illness, or unknown reasons  
n = 15 (6 men 1 and 9 women 2) 
8 Excluded  
 Did not meet the 9-month-after GCMI 
criteria  
n = 2 (1 man1, 1 woman 2)  
 Retransitioned (regret)  
n = 2 (assigned male at birth) 
 No gender-confirming genital surgery and 
no legal gender change  
n = 4 (2 male identified, assigned female at 
birth, 2 female identified, assigned male at 
birth) 
Final sample 
65 participants 
16 men 1 
49 women 1 
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Measurements 
Self-developed questionnaire 
A questionnaire was developed to obtain sociodemographic information, history of treatment 
of gender dysphoria, questions about gender congruence, requests for re-transition, self-
identification, how the subjects were perceived by others, subjects’ satisfaction with their 
physical appearance with regards to aspects of femininity or masculinity, childhood 
adversities, and adult stressful life events. The questionnaire also recorded sexual orientation, 
age of onset of gender dysphoria, and history of suicide attempts. 
 
Clinical Global Impression Improvement (CGI-I) 
The participants rated their overall improvement after gender-affirming medical 
interventions and change of legal gender with the Clinical Global Impression Improvement 
Scale (CGI-I), graded from 0, (“very much worse”) to 6 (“very much improved”). The CGI-
I was dichotomized into either improved (“very much improved” or “very improved” 
[scoring 6 and 5]) or “not improved” (scoring < 5). 
 
Mini International Neuropsychiatric Interview (M.I.N.I. 5.0.0b) 
Psychiatric morbidity was assessed with the Mini International Neuropsychiatric Interview 
(MINI 5.0.0b), which is a structured interview for the assessment of current and lifetime 
psychiatric morbidity according to the DSM-IV (Sheehan et al., 1998). M.I.N.I. interviews 
were conducted by either a consultant psychiatrist or a trained research nurse. 
 
Adult ADHD Self-Report Scale Screener (ASRS-V1.1 Screener) 
The Adult ADHD Self-Report Scale Screener (ASRS-V1.1 Screener) was used to screen for 
attention-deficit/hyperactivity disorder (ADHD). The ASRS-V1.1 screener is the official 
WHO screening instrument for ADHD that correlates with the full ASRS version (Kessler et 
al., 2007). The screener has four inattention items and two hyperactivity items. The likelihood 
of a clinical diagnosis of ADHD is high if 4 of 6 criteria are met (Kessler et al., 2007). 
 
The Autism Spectrum Quotient (AQ) 
The Autism Spectrum Quotient (AQ) Scale was used to screen for autistic traits. The AQ was 
developed to provide a brief self-report measure of autistic traits (Baron-Cohen, Wheelwright, 
Skinner, Martin, & Clubley, 2001). The maximum score is 50. A cut-off score of 32 has been 
shown to be an acceptable sensitivity (0.77) and specificity (0.74) for capturing an autism 
spectrum diagnosis (Woodbury-Smith, Robinson, Wheelwright, & Baron-Cohen, 2005). 
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Alcohol Use Disorders Identification Test (AUDIT) 
Alcohol use was measured by the Swedish version of the Alcohol Use Disorders 
Identification Test (AUDIT), which has been validated to identify hazardous patterns of 
alcohol consumption (Bergman & Källmén, 2002; Bohn, Babor, & Kranzler, 1995). The 
scale comprises 10 items and the maximum total score is 40 points. Scores above 6 for 
cisgender women and above 8 for cisgender men are regarded as indicators of harmful 
drinking (Berman, Wennberg, & Källmén, 2012). 
 
Questions about sexual abuse 
The questions about sexual abuse have been used previously in a national population-based 
study in Sweden, “Sex in Sweden” (Swedish National Institute of Public Health, 2000), 
which enabled us to compare results of this study with population data. 
 
Statistical analyses 
Descriptive data were expressed as means (SD) and medians (range) for continuous variables, 
and as numbers (percentages) for categorical variables. Percentages were calculated based on 
those who completed the respective questions. For group comparison, the Mann-Whitney U 
test for group comparisons of continuous or ordinal variables was used since the data did not 
meet the assumptions of a normal distribution according to the Kolmogorov-Smirnov test. For 
categorical variables, Fisher’s exact test and chi-square were used as appropriate. A logistic 
regression analysis was performed to test which variables were associated with a current 
psychiatric illness. The dependent variable was current psychiatric morbidity (Yes/No). 
Predictor variables with p < 0.05 (Table 5) were considered for inclusion in the model. These 
variables were: childhood maltreatment, childhood sexual abuse, born abroad, not accepted in 
assigned gender, and victim of a crime related to transgender background. Given the low 
number of study subjects, the number of predictor variables in a logistic regression analysis 
should preferably be 4 or less. We therefore merged childhood maltreatment and childhood 
sexual abuse into one predictor variable. Being on sick leave and not being accepted in the 
assigned gender at work was considered to be a consequence of having a psychiatric disorder 
and therefore was not included in the model. A forward stepwise elimination via the Wald 
statistics (“Enter”) was used. A p-value < 0.05 was regarded as significant. The statistic 
calculations were done using IBM SPSS Statistics 22. SPSS, Chicago, IL, USA. 
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3.5 ETHICAL CONSIDERATIONS 
All studies were approved by the Regional Ethical Review Board in Stockholm. The National 
Board of Health and Welfare granted permission to review the files of all applications for legal 
and surgical gender reassignment. 
In Study I and IV all participants and controls gave informed consent to participate and the 
studies were conducted according to the Helsinki declaration. 
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4 MAIN RESULTS 
4.1 STUDY I, NEUROBIOLOGICAL TRAITS 
In the whole-brain analysis, cisgender females and males differed in their brain activation when 
smelling the steroidal compounds, AND and EST. In cisgender females, anterior hypothalamus 
was activated when smelling AND and olfactory parts of the brain when smelling EST. In 
cisgender males, the posterior hypothalamus was activated when smelling EST and olfactory 
parts of the brain when smelling AND. There were no differences when participants smelled 
common odors. 
Transgender women differed significantly from cisgender males, but not cisgender women, in 
how the brain was activated when smelling AND and EST. There were no differences in brain 
activation from cisgender controls when they smelled common odors. 
To examine not only if they differed from cisgender controls but also shared activation clusters, 
conjunctional analyses were made. The result of the conjunctional analyses showed that not 
only AND but also EST elicited a hypothalamic brain activation. Thus they shared 
hypothalamic activation for AND with cisgender women and for EST with cisgender men. 
However, the hypothalamic activation caused by EST was less strong than that caused by AND. 
Hence, despite a common cluster seen in the conjunctional analyses with cisgender males, they 
did not differ significantly when compared directly with cisgender female controls regarding 
the EST activation. The regional post-hoc analyses, in predefined areas of the hypothalamus, 
did not reveal anything further.  
In conclusion, transgender women activated the brain in response to the steroidal compound 
AND in the same way as cisgender women, and differently to cisgender males. However, they 
also had cisgender male features when smelling EST, albeit not strong enough to make them 
different from cisgender women.  
 
Strength and limitations 
Not only perceived gender identity seems to effect hypothalamic response to AND and EST, 
but also sexual orientation. Homosexual (androphilic) cisgender males had a similar 
hypothalamus activation pattern to cisgender women (Savic et al., 2005). In this study, the 
transgender women were gynephilic and thus homosexual in relation to their gender identity. 
Whether the hypothalamic response to AND and EST is driven by perceived gender identity, 
and or sexual orientation towards someone with the same gender identity needs to be further 
examined. All but one of the transgender participants stated that they had gender dysphoric 
feeling before the age of 7 years old, but we did not assess whether they fulfilled the diagnostic 
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criteria for gender dysphoria in childhood. A strength is that the diagnostic assessment was 
performed by an experienced gender team and that all transgender participants were diagnosed 
with Transsexualism F64.0 (World Health Organization, 1992). 
4.2 STUDY II, INCIDENCE OF GENDER DYSPHORIA AND POSTOPERATIV 
REGRETS  
Number of applications, age, sex ratio, and outcome 
A total of 767 people (289 assigned female at birth and 478 assigned male at birth) applied for 
legal and surgical sex reassignment in Sweden due to gender dysphoria during the period 1960-
2010 (Figure 2). Of these 767 applicants, 89% or 681 persons (transgender men: 252/289, 87%; 
transgender women 429/478, 90%) were granted a new legal gender and had undergone 
gender-affirmation surgery by the end of June, 2011. The median (min-max) age at application 
for the whole period was 27 years (16-65) for transgender men and 32 years (15-75) for 
transgender women. 
 
 
Figure 2. New applicants for a new legal sex and permission for gender-affirming genital 
surgery to the National Board of Health and Welfare in Sweden 1960-2010, per year, 
males and females as assigned at birth. 
 
Incidence 
The incidence of applications was calculated and stratified over four periods between 1972 and 
2010. For transgender men, the incidence increased from 0.16 to 0.42/100,000/year. For 
transgender women, the incidence increased from 0.23 to 0.73/100,000/year. The most 
dramatic increase occurred during the period 2001-2010. 
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The proportion of transgender men 30 years or older at the time of application remained stable 
at around 30%. In contrast, the proportion of transgender women 30 years or older increased 
from 37% in the first decade to 60% in the latter three decades. 
For the whole period (1960-2010), the transgender men: transgender women ratio was 1:1.66, 
but fluctuated over time: 1:1.42 (1972-1980), 1:1.33 (1981-1990), 1:1.93 (1991-2000) and 
1:1.70 (2001-2010). 
 
Prevalence 
The point prevalence at December 31, 2010 for persons who applied for a new legal gender 
was for transgender men 1:13,120 (0.008%) and for transgender women 1:7,750 (0.013%). 
 
Postoperative regrets 
A total of 15 individuals (5 transgender men and 10 transgender women) out of 681 who 
received a new legal gender between 1960-2010 applied for reversal to the gender assigned at 
birth (regret applications). This corresponds to a regret rate of 2.2% for both sexes (2.0% 
transgender men and 2.3% transgender women). As showed in Table 11, the regret rate 
decreased significantly over the whole study period (p < 0.0001, Fisher’s exact test). The 
median (min-max) age at which this group first applied for a new legal sex was 22 (18-52) 
years in transgender men and 35 (27-49) years in transgender women. The median (range) time 
elapsed from attaining a new legal gender to the regret application was 7.5 years (90 months, 
range 75-137) for transgender men, and 8.5 years (102 months, range 22-177) for transgender 
women. 
Table 11. Individuals who subsequently apply for reversal to the original sex 
 
Time period Number of sex-reassigned individuals in the time period when 
they made their first application who later applied for reversal 
to the assigned sex at birth/ total number of individuals who 
made their first application in this time period and received a 
new legal sex (%) 
Number of regret 
applications during 
that time period 
1960-1971 4/15 (27 ) 0 
1972-1980 6/103 (5.8) 5 
1981-1990 1/76 (1.3) 3 
1991-2000 3/127 (2.4) 3 
2001-2010 1/360 (0.3) 4 
1960-2010 
 
15/681 (2.2 ) 15 
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Strengths and limitations 
A limitation of Study II is that the point prevalence is slightly overestimated since we were not 
able to exclude those who died after sex reassignment and those who were born outside 
Sweden. We did not include data on sociodemographic variables, prior psychiatric morbidity, 
sexual orientation and onset age of gender dysphoria. Hence, we could not evaluate these 
factors in relation to the increased incidence, changes of sex ratio, and postoperative regret. 
Notably, the study examined applications for legal and surgical sex reassignment and not 
gender dysphoria diagnoses. However, a gender dysphoria diagnosis is required to be granted 
a new legal sex. This study is unique as it represents a complete national cohort of people who 
have applied for legal gender change in Sweden over the past 50 years. The quality of the data 
is assured by access to all the original files and applications since 1960 and by the legal 
framework regulating legal sex change in Sweden. The methodology was similar to previous 
Swedish studies, which allows for comparisons (Landén et al., 1996; Olsson & Möller, 2006; 
Wålinder, 1971). 
4.3 OVERVIEW OF POSTTRANSITION OUTCOMES (STUDY III AND IV) 
Table 12 shows an overview of outcomes in Study III and IV. 
Table 12. Overview of study characteristics, sociodemographics and outcomes for 
participants in study III, IV. 
 
Study  Study III 
 
Study IV 
 
Study characteristics   
Type of study  matched case control cross-sectional 
Time period 1973-2003 1972-2009 
Number of participants 324 65 
Follow-up time mean (SD, min-max) 11.4  7.2 (7.3, 0.75-30.5) 
Age at legal and surgical reassignment mean (SD, min -max) 35.1 (9.7, 20-69) 36.2 (11.6, 18.1-64.6) 
 
Sociodemographics n/N (%) 
  
Immigrant status, not born in Sweden 70/234 (22)1 10/63 (16) 2 
Urban living area 291/234 (10)1 53/63 (84)2 
More than 10 years of schooling or post-high school prior to entry 
(Study III) or at examination (Study IV) 
151/324 (58)1 
 
39/64 (61)2 
 
Outcome post transition n/N (%) 
  
Psychiatric inpatient care post transition (Study III) 
or current psychiatric morbidity assessed by MINI (Study IV) 
64/324 (19.8) 16/65 (24.6) 
Psychiatric inpatient care for suicide attempts post transition (Study 
III) 
or self-reported suicide attempt post transition (Study IV) 
29/324 (9.0) 8/64 (12.5) 
Alcohol/substance abuse inpatient care post transition or current 
hazardous drinking, assessed by AUDIT 
22/324 (6.8) 1/65 (1.5) 
1 prior to study entry  2 at examination 
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4.4 STUDY III, MORTALITY, PSYCHIATRIC MORBIDITY POST TRANSITION 
Characteristics of participants and controls prior to sex reassignment 
Individuals who were post-legal and surgical transition were hospitalized for psychiatric 
morbidity other than Gender Identity Disorder prior to treatment about four times more often 
than cisgender controls. They were twice as likely to have immigrant status compared with 
cisgender controls. There were no significant differences between assigned females at birth or 
assigned males at birth regarding measured baseline characteristics. 
 
Mortality 
Individuals of both genders who had undergone legal and medical transition had approximately 
three times higher all-cause mortality than controls of sex assigned at birth, even after 
adjustment for covariates. Table 13 displays the various outcomes for the whole period, 
separated depending on whether the sex reassignment was performed 1973-1988 or 1989-2003. 
For the latter period the participants did not differ from controls. The higher all-cause mortality 
was also true when comparing with controls of reassigned sex and for both assigned females 
and male at birth analyzed separately. Kaplan-Meier curves show that survival of transgender 
men and transgender women start to diverge after about 10 years of follow-up. 
 
Psychiatric morbidity and suicide attempts 
Individuals of both genders who had undergone sex reassignment had an approximately three 
times higher risk of inpatient care for any psychiatric disorder other than gender dysphoria 
when adjusted for immigrant status and psychiatric morbidity prior to entry, compared with 
birth sex controls. This increase was seen regardless of whether the sex reassignment took place 
before or after 1989. In line with the increased mortality in suicide there was an increased risk 
of hospitalization for attempted suicide compared to controls for the period prior to 1989. There 
were no differences compared with controls regarding hospitalization for substance misuse or 
accidents. 
 
Strengths and limitations 
First, this study reflects the outcome of psychiatric and somatic treatment for gender dysphoria 
provided in Sweden during the 1970s and 1980s. Since then, treatment has evolved with 
improved gender-affirming surgery (Eldh et al., 1997; Sigurjonsson, Rinder, Möllermark, 
Farnebo, & Lundgren, 2015), refined hormonal treatment and more attention to psychosocial 
care (Hembree et al., 2009), which might have improved the outcome. Supporting this notion, 
the trans persons did not differ regarding mortality and suicide attempts compared with controls 
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during the last fifteen years of the follow-up period. On the other hand, the mortality rates 
started to diverge after 10 years and the mortality rate might increase for those included the last 
five years. Second, gender dysphoria is a rare condition and Sweden has a small population 
(9.2 million inhabitants in 2008). Hence, despite being based on a comparatively large national 
cohort and long-term follow-up, the statistical power was limited. Third, regarding psychiatric 
morbidity after sex reassignment, we assessed inpatient psychiatric care. Since most psychiatric 
care is provided in outpatient settings (for which no reliable data were available), 
underestimation of the absolute prevalence of psychiatric morbidity was inevitable. However, 
there is no reason to believe that this would change the relative risks for psychiatric morbidity 
unless individuals who are post legal and surgical transition were more likely than matched 
controls to be admitted to hospital for any given psychiatric condition. In other words, since 
the same approach was taken for cases and controls, this would not affect risk estimates if the 
same degree of underestimation occurred. 
The strengths of this study include nationwide data collected representatively over more than 
30 years, extensive follow-up time, absence of selection bias, and minimal loss to follow-up. 
Many previous studies suffer from low outcome ascertainment (De Cuypere et al., 2005; Eldh 
et al., 1997; Lawrence, 2003), but our study should have captured almost the entire population 
of sex-reassigned transgender individuals in Sweden during 1973-2003. Moreover, previous 
outcome studies have mixed pre-operative and post-operative transgender persons (Bodlund 
& Kullgren, 1996; Johansson et al., 2010; Vujovic et al., 2008), whereas we included only 
post-operative transgender persons evaluated clinically by a specialized psychiatrist or 
gender dysphoria team during at least 2 years and then re-evaluated by specialists at the 
National Board of Health and Welfare before becoming eligible for gender-affirming genital 
surgery and legal sex reassignment. Finally, whereas previous studies either lack a control 
group or use standardized mortality rates or standardized incidence rates as comparison (De 
Cuypere et al., 2005; Gooren, Giltay, & Bunck, 2008; van Kesteren et al., 1997), we selected 
random population controls matched by birth year, and either birth or final sex. 
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Table13. Risk of various outcomes among sex-reassigned subjects in Sweden (N=324) compared 
with population controls matched for birth year and birth sex. 
 
Outcomes 
Number of 
events cases/ 
controls 
1973-2003 
Outcome incidence rate 
per 1000 person-years 
1973-2003 
(95% CI) 
Crude 
hazard ratio 
(95% CI) 
1973-2003 
Adjusted1 
hazard ratio 
(95% CI) 
1973-2003 
Adjusted1 
hazard ratio 
(95% CI) 
1973-1988 
Adjusted1 
hazard ratio 
(95% CI) 
1989-2003 
  Cases Controls     
Any death 27/99 7.3 
(5.0-10.6) 
 
2.5 
(2.0-3.0) 
2.9 
(1.9-4.5) 
2.8 ( 
1.8-4.3) 
3.1 
(1.9-5.0) 
1.9 
(0.7-5.0) 
 by suicide 10/5 2.7 
(1.5-5.0) 
 
0.1 
(0.1-0.3) 
19.1 
(6.5-55.9) 
19.1 
(5.8-62.9) 
N/A N/A 
 by 
cardiovascular 
disease 
 
9/42 2.4 
(1.3-4.7) 
1.1 
(0.8-1.4) 
2.6 
(1.2-5.4) 
2.5 
(1.2-5.3) 
N/A N/A 
 by neoplasm 8/38 2.2 
(1.1-4.3) 
1.0 
(0.7-1.3) 
2.1 
(1.0-4.6) 
2.1 
(1.0-4.6) 
 
N/A N/A 
Any psychiatric 
hospitalization2 
64/173 19.0 
(14.8-24.2) 
4.2 
(3.6-4.9) 
4.2 
(3.1-5.6) 
2.8 
(2.0-3.9) 
3.0 
(1.9-4.6) 
2.5 
(1.4-4.2) 
 Substance 
abuse 
22/78 5.9 
(3.9-8.9) 
1.8 
(1.5-2.3) 
3.0 
(1.9-4.9) 
1.7 
(1.0-3.1) 
N/A N/A 
Suicide attempt 29/44 7.9 
(5.5-11.4) 
1.0 
(0.8-1.4) 
7.6 
(4.7-12.4) 
4.9 
(2.9-8.5) 
7.9 
(4.1-15.3) 
2.0 
(0.7-5.3) 
Any accident 32/233 9.0 
(6.3-12.7) 
5.7 
(5.0-6.5) 
1.6 
(1.1-2.3) 
1.4 
(1.0-2.1) 
1.6 
(1.0-2.5) 
1.1 
(0.5-2.2) 
Any crime 60/350 18.5 
(14.3-23.8) 
9.0 
(8.1-10.0) 
1.9 
(1.4-2.5) 
1.3 
(1.0-1.8) 
1.6 
(1.1-2.4) 
0.9 
(0.6-1.5) 
 Violent crime 14/61 3.6 
(2.1-6.1) 
1.4 
(1.1-1.8) 
2.7 
(1.5-4.9) 
1.5 
(0.8-3.0) 
N/A N/A 
1 Adjusted for psychiatric morbidity prior to baseline and immigrant status. 
2 Hospitalizations for Gender Identity Disorder were excluded.  
N/A = Not applicable due to sparse data 
 
4.5 STUDY IV, GENDER CONGRUENCE, PSYCHIATRIC MORBIDITY, AND 
REALTION TO CHILDHOOD ADVERSITIES AND ADULT STRESSFUL LIFE 
EVENTS POST TRANSITION 
Characteristics and sociodemographics of the participants 
Sixty-five individuals (16 men assigned female at birth, and 49 women assigned male at 
birth) participated, which constitutes 11.1% (7.3% of men and 13.4% of women) of the total 
sex-reassigned population in Sweden at the time of the study. The mean (SD) follow-up time 
was 7.2 (7.3) years with a median of 4.3 (range 0.75-30.5) years. 
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Gender congruence, global clinical impression improvement 
Gender congruence 
The vast majority, 91.9% (57/62), felt gender-congruent after transition (men, 16/16, 100%; 
women, 41/46, 89.1%). Self-identification was in agreement with the new assigned gender 
for a majority (all, 49/61, 80.3%; men, 13/16, 81.3%; women, 36/45, 80.0%); the remaining 
individuals reported a transgender identity. More men (15/16, 93.8%) than women (34/46, 
73.9%) reported that other people perceived them as being of their new assigned gender. All 
men and 37 of 46 (80.4%) women were satisfied with how their physical appearance reflected 
their assigned gender. No one expressed a wich to retransition. 
 
Clinical Global Impression Improvement 
With respect to improvement after gender-affirming health care as measured by CGI-I, a 
majority reported improvement (all, 52/64, 81.3%; men, 15/16, 93.8%; women, 37/48, 
80.4%). 
 
Suicide attempts and psychiatric morbidity 
Lifetime suicide attempt was reported by 40%. All suicide attempts post transition were 
committed by women. There was a decrease in individuals reporting suicide attempts: 36% 
before versus 13% after. In the total cohort, 41.5% had any current or lifetime psychiatric 
diagnosis, and a quarter of the participants had one or more current psychiatric diagnoses. 
Depression was the most common diagnosis. No participant suffered from any present or 
previous psychosis. No participant met the criteria for current alcohol misuse or substance 
abuse disorder, but the AUDIT instrument revealed that 12.7% had hazardous alcohol 
consumption when the cut-off score for women was used and 4.8% when the cut-off score 
for men was used. According to the ASRS-V1.1 Screener, 13.3% of the participants screened 
positive for ADHD. One woman scored 32 on the AQ scale, indicating autism spectrum 
disorder. 
 
Child adversities and adult stressful life events 
More than 90% of the individuals had experienced some childhood adversity or some adult 
stressful life event. Any childhood adversity was reported by more than three quarters of the 
participants. All cases of childhood sexual abuse were reported by women. 
At least one adult stressful life event was reported by more than three quarters of the 
participants. Harassments, discrimination, and being a victim of crimes related to their 
transgender background occurred both before, during, and after transition. Not being accepted 
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as the correct gender by at least one family member, health care worker, work or school 
colleague, or friend was reported by 56%. Almost one third reported sexual abuse as adults. 
The sexual abuse reported by the three men had occurred before transition. The 16 women 
who reported sexual abuse as adults were abused before, during, and after transition. 
 
Relationship between psychiatric morbidity and childhood adversities 
A quarter of the participants displayed some current psychiatric morbidity. A logistic 
regression analysis was performed to test which variables were associated with current 
psychiatric morbidity. Current psychiatric morbidity as predicted by being born abroad, 
childhood maltreatment or childhood sexual abuse, and not being accepted in assigned gender 
by at least one other party (Table 14). 
 
Table14. Logistic regression analysis of current psychiatric morbidity (dependent 
variable) for selected clinical variables (see text). 
 
 OR (95% CI) p-value 
Childhood maltreatment or sexual abuse 12.3 (2.0-77.9) 0.008 
Not born in Sweden 18.3 (1.9-176.3) 0.012 
Not accepted as correct gender by at least one family member, 
health care worker, work or school colleague, or friend 
  9.0 (1.5-52.2) 0.015 
Victim of crime related to transgender background   2.3 (0.5-11.6) 0.292 
 
Strengths and limitations 
Low power due to small sample sizes is common in transgender research. We captured 11% 
of the total population that had changed their legal gender and underwent gender-affirming 
genital surgery in Sweden. In spite of this, our sample size was 65, which limits the statistical 
power. Further, the selection procedure was not random and a selection bias may have 
occurred. However, age at time for legal and social transition, immigrant status, living in 
cities, the high prevalence of psychiatric morbidity and suicide attempts is in line with 
previous register studies in Sweden that captured almost all sex-reassigned individuals 
(Dhejne et al., 2011). Also, the age of the study group matches the age of the group that we 
did not capture. Information on childhood adversities and adult stressful life events was 
sometimes captured long after the events occurred and might be subject to recall bias. 
A strength of the study is that all participants were post transition and had no incentive to 
adjust their answers to achieve a desired treatment, which is common in studies prior to 
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gender-affirming health care. Indeed, one study reported that 44% of the participants gave a 
falsified story at assessment (Pimenoff & Pfäfflin, 2011). 
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5 GENERAL DISCUSSION 
5.1 NEURAL CORRELATES OF GENDER DYSPHORIA 
The results showed that gynephilic transgender women resembled cisgender female controls 
with regards to hypothalamic activation of steroids compounds AND and EST, even if they 
also shared activation patterns with cisgender males. The findings are in line with a recent 
functional magnetic resonance imaging (fMRI) study, which reported that gender dysphoric 
transgender adolescent girls and boys who smelled androstendione both had a hypothalamic 
activation pattern in line with their experienced gender identity (Burke, Cohen-Kettenis, 
Veltman, Klink, & Bakker, 2014). In contrast, prepubertal gender dysphoric boys had an 
activation pattern similar to cisgender boys, and prepubertal gender dysphoric girls were 
similar to neither cisgender girls nor to cisgender boys. Gender dysphoric prepubertal children 
are more heterogenic compared with gender dysphoric adolescents, which may explain the 
divergent results. Interestingly, the cisgender prepubertal and adolescent controls both showed 
gender differences in response to androstendione, thus indicating that the sex differences are 
present before puberty and maybe even be established prenatally (Burke et al., 2014). The 
findings that transgender women also shared some activation pattern with cisgender male 
controls accords with morphological and functional brain studies reporting that transgender 
individuals possess an intermediate position between cisgender females and males, or not 
resembling either of them (Junger et al., 2014; Junger et al., 2013; Kranz et al., 2014; Lin et al., 
2014; Rametti, et al., 201a; Rametti et al., 2011a). Another line of neurobiological studies has 
instead of searching for resemblance or non-resemblance with cisgender females or males, 
investigated the experience per se of gender incongruence/gender dysphoria. They suggest that 
cerebral networks involved in body image and self-perception (the internal representation of 
physical appearance) could be altered in gender dysphoric individuals (Feusner, et al., 2016; 
Feusner, et al., 2016; Manzouri, Kosidou, & Savic, 2015). Questions have also been raised as 
to whether gender dysphoria is caused by the same mechanisms in transgender men, 
transgender women and other subgroups in the population (Smith et al., 2015). It has also been 
suggested that a spectrum view would be preferable to trying to fit in gender dysphoric 
individuals in more – or less – male or female features (Smith et al., 2015). Future studies 
should – besides ICD or DSM diagnoses – provide more detailed phenotypes and describe their 
participants on many different levels. 
This study adds to the literature in that it indicates a neurobiological background to gender 
dysphoria. However, this notion does not have far-reaching clinical implications, as a brain 
scan cannot be used to find out whether or not a patient is suffering from gender dysphoria. 
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The diagnosis of gender dysphoria is currently based solely on medical history: the personal 
experience of gender incongruence, body dysphoria et cetera and whether any other condition 
better explains the feeling of gender incongruence or gender dysphoria (Bockting, Knudson, & 
Goldberg, 2006; Coleman et al., 2012). 
5.2 INCREASE OF GENDER DYSPHORIA 
We found that the incidence of application for legal and surgical sex reassignment increased 
dramatically over the 50-year study period. This parallels other reports and a recent meta-
analysis (Arcelus et al., 2015). It has not yet been clarified why this increase has occurred. 
Among conceivable reasons are that more individuals come forward and seek help, and that 
more transgender persons are deemed eligible for sex reassignment. Gender dysphoria per se 
may also have increased in the population. Population studies of gender dysphoria are scarce, 
but suggest that what we see clinically is the tip of an iceberg. Gender dysphoric symptoms 
(feelings of gender incongruence and a wish for gender-affirming treatment) were in the 
Netherlands reported by 0.2% of assigned females and 0.6% of assigned males (Kuyper & 
Wijsen, 2013). Increased openness and visibility of transgender persons in the society and 
better access to care have been suggested as reasons prompting help-seeking behavior (Arcelus 
et al., 2015; Dhejne et al., 2014). Individuals with autism spectrum disorder or unstable 
psychosocial situations used to be seen as less eligible for legal and medical transition (Landén 
& Rasmussen, 1997; Lundström & Wålinder, 1985). This has slowly changed over the last 
twenty years, and could explain some of the increased incidence (Glidden et al., 2016). 
 
Implications 
Transgender health care in Sweden is not currently scaled for the increase in individuals 
seeking gender-affirming treatment. Hence, there are long waiting lists both to start evaluation, 
and to commence gender-affirming treatment. There is also a waiting list at the Board of 
National Health and Welfare that handles applications for a new legal gender and permission 
for gender-affirming genital surgery. Given that gender-affirming treatment and legal 
recognition decrease gender dysphoria (Heylens, et al., 2014b; Johansson et al., 2010; Murad 
et al., 2010), improve general health (Zeluf et al., 2016), and reduce psychiatric morbidity it is 
important to increase access to health care and legal gender recognition (Reisner et al., 2016b; 
Winter et al., 2016). With increasing numbers of transgender persons seeking health care, there 
is also a need for more general knowledge of transgender medicine in the whole health care 
system. Transgender medicine needs to be included in the education curriculum of all health 
care professionals (Arcelus & Bouman, 2015; Safer, 2016; Safer & Pearce, 2013). 
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5.3 MORTALITY 
We found that individuals of both genders who had undergone legal and surgical transition 
1973-2003 had an approximately three times higher all-cause mortality than controls of sex 
assigned at birth, even after adjustment for covariates. There was an improvement over time, 
and for the period 1989-2003 the participants did not differ from controls. Major causes of 
death were suicide and cardiovascular disease. Transgender persons did not differ from 
controls with regards to cancer. The findings accord with previous studies (Asscheman et al., 
2011; Blosnich et al., 2014; Simonsen et al., 2016a), even though the Dutch study did not find 
any increased mortality for transgender men (Asscheman et al., 2011). The inconclusive 
finding regarding transgender men needs to be further examined. A recent review concludes 
that current data support the safety of physician-supervised cross-sex hormone treatment 
(Weinand & Safer, 2015), but long-term large studies regarding the safety aspects of 
transgender medicine are needed (Feldman et al., 2016; Reisner et al., 2016a; Weinand & 
Safer, 2015). 
5.4 REGRETS 
We found the regret rate to be 2.2% and declining. The regret rate is lower that reported by 
Landén et al. (1998b) (3.8%). However, Landén et al. (1998b) reported a mean latency for 
applying for reversal of 7.4 years, which matches the median latency time in our study: 7.5 
years for assigned females at birth and 8.5 years for assigned males at birth. This means that 
some of the 360 individuals who were granted a new legal sex during 2001-2010 may later 
apply for retransition. Landén et al. (1998b) had the same disclaimer. Indeed, three additional 
individuals who received a new legal sex 1991-2000 regretted their transition. 
However, the trend is fewer regret applications over time: 11 of the 15 regrets applied for a 
new legal gender before 1991. This could indicate that transgender health care – including the 
evaluation process, hormone treatment, and surgical treatment – has improved. 
The rate of regret did not differ depending on assigned sex at birth, but the individuals who 
regretted the transition were somewhat older at the time of application than those who did not 
regret the procedure (median 35 years compared with 32), which is sometimes seen as a sign 
of late onset gender dysphoria. On the other hand, the proportion of applicants over 30 years 
old has been stable (60%) since 1981 and the regret rate is nevertheless declining. Recent 
follow-up studies have not found any difference in outcome in relation to gender, age of onset 
or sexual orientation (Johansson et al., 2010; Nieder et al., 2016). Predictors for regret in the 
study by Landén et al. (1998b) were poor family support, late onset gender dysphoria 
(secondary transsexualism) in trans women, and a history of psychotic disorders. Since then, 
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support to next-of-kin is included in Swedish transgender health care. This may have 
contributed to the declining regret rate and is in line with other studies reporting a better general 
outcome for those with good social support. 
Studies that examined predictors for regret are hampered by small samples (Eldh et al., 1997; 
Landén et al., 1998b; Lindemalm et al., 1987) due to the low regret rate and low prevalence of 
gender dysphoria in the population. This may explain some discrepancies in the literature, such 
as whether or not late onset or secondary gender dysphoria are risk factors (Bodlund & 
Kullgren, 1996; Johansson et al., 2010; Landén et al., 1998b). Fear of regret probably underlies 
the recommended step-wise procedure including a diagnostic evaluation time, then initiation 
of reversible or partly reversible gender-affirming treatment prior to irreversible genital surgery 
(Coleman et al., 2012).The importance of a slow process is also mirrored in the Swedish 
legislation and in the Swedish national guidelines. However, we noted that the mean time 
between the first visit at any clinic for gender dysphoria and a new legal gender declined 
gradually from 7.25 years between 1972 and 1980, to 3.8 years between 2001 and 2010. At 
the same time the regret rate decreased from 5.8% to 0.3% indicating that a somewhat quicker 
process did not increase the regret rate. There is no study evaluating the association between 
regret and the evaluation time, but one study compared an early surgery group with a group of 
patients on a surgery waiting list and found better mental well-being in the operated group 
(Mate-Kole, Freschi, & Robin, 1990).  
 
Implications 
It is important to continue recording regrets. To go beyond quantitative studies and add 
qualitative studies would further our understanding of regret. Questions of interest would be: 
was the person actually gender dysphoric and received the correct treatment? Or was the person 
disappointed by the limits of gender-affirming treatments? Did the person regret certain steps, 
but not all of the gender-affirming treatment? Or did the person have other reasons to 
retransition? Randomized studies aiming to evaluate different evaluation and treatment 
protocols in relation to regret or less favorable outcomes would also be helpful 
5.5 PSYCHIATRIC MORBIDITY, SUICIDALITY AND VULNERABILITY 
We found that psychiatric morbidity, including suicide attempts, was more common in 
transgender persons compared with assumed cisgender controls. In the cross-sectional study, a 
quarter had a current psychiatric morbidity; depression and anxiety disorder were most 
common. Both findings accord with a recent review of mental health problems in the 
transgender group (Dhejne et al., 2016). The studies included in this thesis did not detect any 
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gender differences in contrast to older Swedish studies (Bodlund & Kullgren, 1996; Wålinder 
et al., 1978), but in line with other more recent studies (Claes et al., 2015; Duisin et al., 2014; 
Johansson et al., 2010). We were also unable to confirm the suboptimal outcomes in gynephilic 
transgender women compared to androphilic transgender women, as found in previous studies 
(Landén et al., 1998b; Smith et al., 2005). Gynephilic transgender women identify themselves 
as lesbians, and belonging to two minority groups may double the level of minority status 
stress. In recent years, being homosexual in Sweden has become less stigmatized (ILGA-
Europe, 2013), which may have affected gynephilic transgender women positively. 
Transgender individuals have also been accepted as members in the Swedish LGBT 
community since 2001. This may have increased perceived social support which is correlated 
to mental wellbeing (Davey et al., 2014). In line with the decreasing regret rate, there was a 
positive trend over time where mortality rate and inpatient care for suicide attempts in 
transgender persons after gender transition did not differ from controls after 1989, even though 
the inpatient psychiatric care remained elevated. The positive time trend may reflect improved 
transgender health care in Sweden. More than 90% of the individuals (with no gender 
differences) in the cross-sectional study had experienced some childhood adversity or some 
adult stressful life event. Harassment, discrimination, and being a victim of crime related to 
their transgender background occurred both before, during, and after transition. The increased 
vulnerability of the transgender group is described in many other reports (Lombardi, 2002; 
Public Health Agency of Sweden, 2015). 
 
Interpretations of suicidality and increased psychiatric morbidity 
How to interpret the high prevalence of psychiatric morbidity and suicidality both before and 
after gender-affirming treatment is the subject of an ongoing debate. By and large, it is either 
seen as a failure of gender-affirming treatment or caused by minority status stress. Those 
interpreting it as a failure of gender-affirming treatment argue that the treatment does not 
improve mental health, or that suicide or suicide attempts may be signs of regret (Levine, 2016; 
Zucker et al., 2016). However, the most common risk factors for suicide and suicide attempts 
are mood disorders and substance abuse, as well as sociodemographic risk factors (Nock et al., 
2008). The prevalence of mood disorder is high prior to gender-affirming treatment (Dhejne et 
al., 2016; Heylens, et al., 2014a). Gender-affirming treatment reduces mental health problems 
caused by gender dysphoria, but mental health problems with another origin will persist, if not 
also treated. 
Another line of reasoning explains the increased mental health issues with the minority stress 
model (Meyer, 2003). Stigma, prejudice including internalized transphobia, and discrimination 
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add stress, which causes an increase in mental health disparities. Resilience, coping, and social 
support can balance the stress, and the model describes the impact on health as a net outcome 
of negative stress and positive processes (Bauer, Scheim, Pyne, Travers, & Hammond, 2015; 
Bockting et al., 2016b; Davey et al., 2014). In support of the minority stress model, we found 
an association between immigrant background and not being accepted by others in assigned 
gender. We were unable to detect any association with known protectors, as other have done 
(Davey et al., 2014; Nuttbrock et al., 2012), however this may be due to a too small sample. 
A third way of addressing the high prevalence of mental health problems in the transgender 
group is to look at models used for explaining psychiatric morbidity in cisgender populations. 
The background to psychiatric morbidity is today seen as function of genetic vulnerability and 
stress factors. Examples of stress factors could be childhood adversities, somatic diseases, drug 
use, and loss of important persons or economy. A recent report from the WHO, the World 
Mental Health Survey in 21 countries (high, middle and low income) concluded that childhood 
adversities had a strong association with all lifetime psychiatric disorders (DSM-IV) (Nock et 
al., 2008). In Study IV we found that childhood adversities were associated with current 
psychiatric morbidity. Similar association between depression/ anxiety disorder and childhood 
maltreatment has been reported from Spain and Italy (Bandini et al., 2011; Bergero-Miguel et 
al., 2016). It is not known whether gender dysphoria is also associated with a genetic 
vulnerability for psychiatric morbidity. 
 
Implications 
Future studies on outcome after gender-affirming treatment would benefit from a valid strong 
outcome measure of gender dysphoria/gender incongruence (Arcelus & Bouman, 2015). The 
high mortality and high rate of mental illness including suicidality stress the vulnerability of 
this group and the importance of improved health care. Gender dysphoric individuals with co-
occurrence of psychiatric disorder should be offered the same psychiatric treatment as 
cisgender individuals. Mainstream psychiatric care needs to be aware that transgender people 
are at risk for suicide and suicide attempts, and needs to increase their knowledge of 
transgender medicine and transgender awareness. Since stigma, discrimination, and abuse are 
common in the transgender group it is important that the health care system collectively – but 
also individuals in the system – does not add to the negative stressors. One way to reduce the 
risk that the health care per se induces stress is by working together with the transgender 
population and their organizations to improve care.  
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6 ON THE IMPACT OF RESEARCH FINDINGS 
Researchers are happy if their findings are recognized and have an impact. However, once 
published, the researcher loses control of how results are used. Study III is the first long-term 
cohort study of mortality and psychiatric inpatient care following gender transition (Dhejne et 
al., 2011). This paper has also had an impact outside the scientific world. Our findings have 
been used to argue that gender-affirming treatment should be stopped since it could be 
dangerous (Levine, 2016). But the results have also been used to show the vulnerability of the 
group and that better transgender health care is needed (Arcelus & Bouman, 2015; Zeluf et al., 
2016). Despite the paper clearly stating that the study is not designed to evaluate whether or 
not gender-affirming is beneficial, it has been interpreted as such. But we do not know what 
would have happened without gender-affirming treatment; the situation may have been even 
worse. As an analogy, similar studies have found increased somatic morbidity, suicide rates, 
and overall mortality for patients treated for depression and bipolar disorder (Ösby, Brandt, 
Correia, Ekbom, & Sparen, 2001). This is important information, but it does not follow that 
antidepressant or mood stabilizing treatment cause the mortality. Most of the articles that use 
the study to argue against gender-affirming health care are published in non-peer reviewed 
papers and the public media in general. These non-scientific publications are difficult to keep 
track of. I am grateful to friends, colleagues, patients, LGBT organizations, and journalists who 
have alerted me when the results of the study have been misinterpreted, giving me a possibility 
to respond to the authors. One could argue that the results should never have been published 
due to the hurt caused to transgender persons. However, not publishing the results would also 
hurt the transgender group and take away an opportunity to receive better health care. 
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7 FINAL REMARKS 
A cisgender person may have difficulty in comprehending the situation for a person with 
gender dysphoria. We need to train in strategies to cope with our spontaneous emotional 
reactions professionally, when challenged with something unfamiliar. This is something that is 
a general part of health care providers’ professional education and training, though in relation 
to situations where fundamental aspects of the gender binary dogma are questioned it is natural 
to react emotionally and leave the paradigm of evidence-based care. In such a situation, 
stringent separation of scientifically-based knowledge from spontaneous opinions or opinions 
based on religious, political, or other platforms is vital but not always given. Once transgender 
individuals are no longer seen as exotic and aberrant, but rather as regular members of society 
there will be general and mental health benefits as well as a reduction in all-cause mortality 
(Arcelus & Bouman, 2015).  
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Table 15. Cross-sectional studies (2000-2016) investigating psychiatric morbidity and 
psychopathology in transgender persons attending transgender health care. 
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Table 15. Cross-sectional studies (2000-2016) investigating psychiatric morbidity and psychopathology in transgender persons 
attending transgender health care. 
Authors 
(year) 
Country 
 
Number of 
trans 
participants 
 
/ mean age at 
assessment 
 
Diagnosis 
 
Treatment 
status: (on 
CHT or post 
GCGS) 
Study design Comparative 
groups 
Outcome 
measure 
Prevalence of psychiatric morbidity 
and psychopathology  
Subgroup differences  
 
/comments 
Haraldsen & 
Dahl (2000) 
Norway 
35 TM  
51 TW  
------------- 
34.0 y TM 
33.3 y TW 
 
DSM-III-R  
DSM-IV 
 
CHT NR  
GCGS Mixed 
pre and post 
surgery 
Single center 
(Gender Clinic) 
Cross-sectional  
CC 1068 
Personality 
disorder (PD) 
101  
 
SCID-I,  
SCID-II  
GAF 
SCL-90-R 
Any Axis I diagnosis (mostly depression 
and anxiety) 33% 
Any Axis II diagnosis 20% 
SCL-90-R as per CC 
Groups: Trans lower 
scores in SCL-90-R than 
PD  
Gender: TW lower SCL-
90-R vs. TM 
 
Miach et al. 
(2000) 
Australia 
82 TW:  
48 GID 
34 GIDAANT 
--------------- 
33.5 y 
 
DSM-III-R 
 
CHT NR  
GCGS 0% 
 
Single center: 
(Gender Clinic) 
Cross-sectional 
GID vs. 
GIDAANT 
 
MMPI-2 
 
Psychopathology:  
Low in 85% of GID 
High in 47% of GIDAANT  
 
GID differs significantly 
in degree of 
psychopathology from 
GIDAANT 
Kersting et al. 
(2003) 
Germany 
12 TM 
29 TW 
--------- 
34.7 y 
 
DSM-IV 
 
CHT NR  
GCGS 17%  
Single center 
(Gender Clinic) 
Cross-sectional  
Psychiatric 
inpatients 115 
Normative 
data 
DES  
SCID-D  
Dissociative symptoms: Trans similar to 
psychiatric inpatients 
 
Limitations: DES and 
SCID-D limited validity 
in trans people 
Hepp et al. 
(2005) 
Switzerland 
11 TM  
20 TW 
------- 
33.2y 
 
DSM-IV 
 
CHT 32%  
GCGS 23%  
Single center 
(Gender Clinic) 
Cross-sectional  
No SCID-I,  
SCID-II 
HADS 
Any Axis I diagnosis, lifetime, ( mostly 
depression and anxiety diagnoses and 
substance abuse) 71%  
Any Axis I diagnosis current, (mostly 
anxiety) 39%  
Axis II diagnosis 42% 
  
No differences, 
regarding gender, age, 
and treatment status 
Kim et al. 
(2006) 
Korea 
43 TW 
--------- 
20.4 y 
DSM-IV 
 
CHT 88%  
GCGS 26% 
 
Single center 
(Identified as part 
of the military 
service 
examination with 
gender dysphoria) 
Cross-sectional  
 
Cisgender men 
47, matched 
for age and 
education 
BDI 
SADS 
SES 
 
BDI (mean) 21.4  
SADS (mean) 13.6 
SES (mean) 16.5 
Trans significantly 
higher scores on 
depression, and social 
anxiety and lower scores 
on self-esteem than 
controls 
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Authors 
(year) 
Country 
 
Number of 
trans 
participants 
 
/ mean age at 
assessment 
 
Diagnosis 
 
Treatment 
status: (on 
CHT or post 
GCGS) 
Study design Comparative 
groups 
Outcome 
measure 
Prevalence of psychiatric morbidity 
and psychopathology  
Subgroup differences  
 
/comments 
Gomez-Gil et 
al. (2008) 
Spain¹ 
56 TM 
107 TW 
---------------- 
27.3 y TM 
29.9 y TW 
 
DSM-IV 
 
CHT NR 
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional  
Normative 
data 
MMPI-2 MMPI-2: Within normal range. 
 
Gender:  
TW not on CHT scored 
higher than on CHT. 
TM no difference 
regarding CHT status 
 
Limitation: Pre-post 
groups were not the 
same 
 
Gomez-Gil et 
al. (2009)¹ 
Spain 
71 TM 
159 TW 
----------- 
27.3 y TM 
29.7 y TW 
 
DSM-IV-TR 
ICD-10 
 
CHT 49% 
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional  
No MINI  Any lifetime psychiatric diagnosis: 
Mood and adjustment diagnoses 71% 
(TM) and 56% (TW) 
Non-alcohol substance 
abuse/dependence 0% (TW) 
Generalized anxiety disorder 9% (TW) 
and 6% (TM)  
Any current psychiatric diagnosis:  
Social phobia 11% (TM) and 8% (TW) 
 
Adjustment disorders 
and substance abuse 
more frequent in TW vs. 
TM 
Madeddu et al. 
(2009) 
Italy 
16 TM 
34 TW 
------ 
31.7 y 
 
DSM-IV-TR 
 
CHT 36%   
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional  
No SCID-II Axis II diagnosis 52%  
Most frequent PD Narcissistic 
 
Gender: no Axis II 
differences  
Weyers et al. 
(2009) 
Belgium 
50 TW 
------------ 
43.06 y 
 
ICD-10 CHT 100%  
GCGS 100%   
Single center 
(Gender Clinic) 
Cross-sectional  
Normative 
data 
SF-36 
 
Mental health problems: 
No difference to normative data 
Relationship: less 
psychopathology if 
in a relationship 
Hoshiai et al. 
(2010) 
Japan 
 
 
349 TM 
230 TW 
------- 
26.5 y TM 
32.0 y TW 
 
DSM-IV 
 
CHT 32%  
GCGS 12%  
 
 
 
 
Single center 
(Gender Clinic) 
Cross-sectional  
No Clinical 
interview 
and clinical 
records 
Any Axis I diagnosis 14%  
Adjustment disorder 7%,  
Anxiety diagnoses 4%,  
Mood diagnoses 1% 
 
Gender: more Axis I TW 
vs. TM  
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Authors 
(year) 
Country 
 
Number of 
trans 
participants 
 
/ mean age at 
assessment 
 
Diagnosis 
 
Treatment 
status: (on 
CHT or post 
GCGS) 
Study design Comparative 
groups 
Outcome 
measure 
Prevalence of psychiatric morbidity 
and psychopathology  
Subgroup differences  
 
/comments 
Bandini et al. 
(2011)² 
Italy 
 
109 TW 
-------- 
36.0 y 
 
DSM-IV-TR 
 
CHT 71%  
GCGS 26%  
Single center 
(Gender Clinic) 
Cross-sectional 
 
Trans with and 
without 
childhood 
maltreatment 
(CM) 
 
Psychiatric 
interview 
SCL-90-R 
Any lifetime psychiatric diagnosis: 
67%(CM) /37% (non-CM) 
SCL-90-R: no difference between 
groups 
 
CM group higher body 
dissatisfaction and worse 
lifetime mental health  
Simon et al. 
(2011) 
Hungary 
17 TM 
30 TW 
-------- 
28.0 y TM 
26.0 y TW 
 
DSM-IV 
 
CHT NR  
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional  
CC 157  
 
SCL-90-R 
 
Psychopathology:  
SCL-90-R: No differences compared to 
controls 
 
Gender: TW elevated 
levels of interpersonal 
sensitivity 
 
Gomez-Gil et 
al. (2012)¹ 
Spain 
74 TM 
113 TW 
------------- 
29.7 y 
ICD-10 
DSM-IV-TR 
 
CHT 36% 
GCGS 42% 
Single center 
(Gender Clinic) 
Cross-sectional  
Trans with and 
without 
treatment  
 
Normative 
data 
SADS 
HAD-A 
HAD-D 
Social anxiety, depression and anxiety: 
SADS, HADS scores normal range 
except for HAD-A.  
Differences CHT or not: CHT group 
lower scores. 
Gender: no difference  
CHT: CHT group better 
when compared to not 
treated 
 
Limitation: Pre-post 
groups were not the 
same 
 
Gorin-Lazard 
et al. (2012)³ 
France 
30TM 
31 TW 
----------- 
29.9y TM 
39.4y TW 
 
DSM-IV-TR 
 
CHT 72% 
GCGS NR 
Multi-center 
(Gender Clinics) 
Cross-sectional  
No BDI  
 
Depression: 
25% significant scores in the BDI 
 
Gender: no difference  
 
Auer et al. 
(2013) 
Germany 
32 TM 
57 TW 
------------ 
32.3 y TM 
47.9 y TW 
 
ICD-10 
 
CHT 100%  
GCGS 65%   
Single center 
(Endocrinology 
Clinic) 
Cross-sectional  
CC336 
matched for 
age and sex 
(natal and 
phenotype)  
SCL-90-R Psychopathology: 
SCL-90-R worse scores on all scales 
compared controls 
 
Gender: Depressive 
symptoms higher in TW 
TM had a profile as cis 
males 
TW were more similar 
to cis females  
Fisher et al. 
(2013)² 
Italy 
 
48 TM  
92 TW 
----------  
32.6 y 
 
DSM-IV-TR 
 
CHT 70%  
GCGS 22%  
Single center 
(Gender Clinic) 
Cross-sectional  
No SCID-I,  
SCID-II 
SCL-90-R 
Any Axis I diagnosis 19%  
Mood and adjustment diagnoses 11% 
Anxiety diagnoses 5% 
Any Axis II diagnosis 4%  
Gender: no difference  
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Gorin-Lazard 
et al. (2013)³ 
France 
31TM 
36 TW 
----------- 
35.1 y 
DSM-IV-TR 
 
CHT 73% 
GCGS NR 
Multi-center 
(Gender Clinics) 
Cross-sectional  
Trans with and 
without CHT 
BDI  
SSEI 
Depression and Self-esteem: 
Trans on CHT less depressive 
symptoms, better self esteem  
CHT: CHT group better 
vs. not on CHT 
 
Limitation: Pre-post 
groups were not the 
same 
 
Davey et al. 
(2014) 
UK 
40 TM 
63 TW 
---------- 
45.7 y 
 
ICD-10 
 
CHT 79%   
GCGS 17 %  
Single center 
(Gender Clinic) 
Cross-sectional  
 
CC 103  
Controlled by 
age  
SCL-90-R  
 
Psychopathology: 
SCL-90-R scores higher in trans 
 
Social support did not 
significantly predict 
psychopathology  
Duisin et al. 
(2014) 
Serbia 
9 TM 
21 TW 
--------- 
30.4 y 
DSM-IV-TR 
 
CHT NR 
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional  
CC 30  
 
SCID-II  
 
Any Axis II diagnosis 67% (most 
frequent paranoid and avoidant) 
 
Difference: GID group 
more Axis II diagnosis 
compared to CC group 
Gender: TW more 
psychopathology vs. TM 
 
Fisher et al. 
(2014)² 
Italy 
59 TM 
66 TW 
------- 
28.7 y TM 
33.1 y TW 
DSM-IV-TR 
 
CHT 0% 
GCGS NR 
Multi-center 
(Gender Clinics) 
Cross-sectional  
Trans with and 
without CHT  
SCL-90-R  
BUT GSI 
Psychopathology:  
No difference between CHT group and 
no CHT group on SCL-90-R. 
BUT GSI: TW with CHT group had less 
body uneasiness than not treated group 
 
Body uneasiness 
effectively diminished 
with CHT 
 
Limitation: Pre-post 
groups were not the 
same 
Judge et al. 
(2014) 
Ireland 
59 TM 
159 TW 
----------- 
32.6 y 
 
DSM-IV-TR 
 
CHT 20% 
GCGS 2% 
Single center 
(Gender Clinic) 
Cross-sectional 
No Psychiatric 
assessment 
by mental 
health 
professional 
Depression (lifetime) 34%  
Schizophrenia 4% 
Bipolar disorder 2%  
High prevalence of 
psychiatric conditions 
 
Limitation: no controls 
Heylens et al. 
(2014 a)  
Belgium 
Germany 
The 
Netherlands 
Norway 
123 TM 
182 TW 
----------- 
22.8-31.2 y TM 
21.6-36.5 y TW 
(Depends on 
country) 
DSM-IV-TR 
 
CHT 0%  
GCGS 0% 
Multi-center  
(Gender Clinics) 4 
countries 
Cross-sectional 
 
No MINI  
SCID-II  
Any lifetime Axis I diagnosis 70%  
Affective problems 60%,  
Anxiety problems 28% 
Any current Axis I diagnosis 38% 
Affective problems 27%, Anxiety 
problems 17% 
Axis II diagnosis 15 %  
 
Gender: no differences 
Age of onset: no 
differences 
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Mazaheri 
Meybodi et al. 
(2014 a) 
Iran 
36 TM 
47 TW 
---------- 
Age: NR 
 
DSM-IV-TR 
 
CHT 93%  
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional  
No SCID-I Axis I diagnosis 63%  
Major depressive disorder 34% 
Specific phobia 21% 
Adjustment disorder 16% 
 
High prevalence of Axis 
I diagnoses  
 
Limitation: no controls 
Mazaheri 
Meybodi et al. 
(2014 b) 
Iran 
31 TM 
39 TW 
---------- 
Age: NR 
 
DSM-IV-TR 
 
CHT 93%  
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional  
No MCMI-II Axis-II diagnosis 81% 
Narcissistic PD 57% 
High prevalence of Axis 
II diagnoses.  
 
Limitation: no controls 
Claes et al. 
(2015) 
UK 
52 TM 
103 TW 
----------- 
34.5 y 
ICD-10 
 
CHT 0% 
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional 
No SCL-90-R 
RSE 
Psychopathology: 
TW reported significantly higher scores 
on paranoid ideation, interpersonal 
distrust, anxiety, depression and 
obsessive-compulsive complaints 
compared with TM 
 
Gender: TW 
significantly lower level 
of self-esteem vs. TM 
Colizzi et al. 
(2015) 
Italy 
33 TM  
85 TW 
----- 
30.2 y 
 
DSM-IV-TR 
 
CHT 0% 
GCGS 0% 
Single center 
(Gender Clinic) 
Cross-sectional  
No DDIS  
DES  
 
Dissociative disorders 30%  
 
Gender: No differences 
Simonsen et 
al. (2015) 
48 TM  
56 TW 
----- 
32.6 y TM4, 37.1 
y TW4 
ICD-8, 9 and 
10 
 
CHT 100% 
GCGS 100% 
National register  
Cross-sectional 
No Psychiatric 
diagnoses in 
National 
register 
Prior to gender transition 
Any psychiatric diagnosis 28% 
After gender transition 
Any psychiatric diagnosis 22% 
 
Gender: No differences 
7% had a psychiatric 
diagnosis both before 
and after gender 
transition 
Bergero-
Miguel et al. 
(2016) 
101 TM 
109 TW  
----- 
27.9 y 
 
ICD-10 
 
NR Single center 
(Gender Clinic) 
Cross-sectional 
No MINI 
BDI-II 
Social anxiety disorder 31% 
(36% TM and 28% TW) 
Mild depression 13% 
Moderate depression 12% 
Serious depression 7% 
 
Social anxiety disorder 
were associated with 
depression, current use 
of cannabis, 
hospitalization of parents 
during childhood and 
immigrant status 
 
BDI = Beck Depression Inventory; BUT-GSI = Body Uneasiness Test Global Severity Index (the total score of BUT); CC = Cis controls; CHT = cross-sex hormonal treatment; CM = 
childhood maltreatment; DES = Dissociative Experience Scale; DDIS = Dissociative Disorders Interview Schedule; GAF = Global Assessment of Functioning scale; GCGS = gender-
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confirming genital surgery; GD = Gender Dysphoria; GID = Gender Identity Disorder; GIDAANT = Gender Identity Disorder of Adolescence and Adulthood, Nontranssexual type; 
HADS = Hospital Anxiety and Depression Scale; HAD-A = HAD-Anxiety, subscale to HADS; HAD-D = HAD-Depression, subscale to HADS; ICD-10 = International Classification 
of Diseases; MINI = Mini International Neuropsychiatric Interview; MMPI-2 = Minnesota Multiphasic Personality Inventory, second version; NR = not reported; RSE = Rosenberg 
Self-esteem Scale; SADS = Social Avoidance and Distress Scale; SCID-I and II = Structured Clinical Interview for DSM-IV, Axis I and II disorders; SCID-D = Structured Clinical 
Interview for DSM-IV Dissociative Disorders;  SCL-90-R = Symptom Checklist-90 (revised); SES = Self-esteem scale; SF-36 = Short Form 36-item Questionnaire; SSEI = Social Self-
esteem Inventory; TM = Transgender men; TW = Transgender women; y = year; ¹,²,³ Studies using same data; 4 age at time for permission for sex reassignment surgery. 
 
